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I. Introduction  1 
I. INTRODUCTION 
Epilepsy is one of the most common neurological disorders of dogs 
and cats as well as one of the conditions with the highest burden in 
human medicine. The disease, known since the ancient times, has 
served for a long time as an insight into the pathophysiology of the 
brain function, since behavioural consequences of a seizure depend 
on where in the brain it originates (KANDEL et al., 2000). 
The nature of seizures has been fascinating the human species since 
antiquity. It had been for a long time believed to be of occult (either 
divine or demonic) origin, even though the relationship between head 
injuries and seizure activity was clear even to ancient Greeks 
(GROSS, 1992; KANDEL et al., 2000). Historical records describe 
predominantly generalised convulsive seizures, with partial seizures 
probably misdiagnosed or overlooked (KANDEL et al., 2000). 
The Renaissance and the epoch of Enlightenment have brought a 
more rational view of the nature of the disease. The rise of post 
mortem examinations allowed physicians, with honourable mentions 
of Paracelsus, Le Pois and Sylvain, to better understand the 
connection between pathologies of the nervous system (such as 
collection of blood or pus in the brain tissue) with the occurrence of 
seizures (GROSS, 1992; PANTELIADIS et al., 2017). Epilepsy has 
been separated from other convulsive conditions (such as hysteria), 
focal seizures have been recognised and designated as “petit mal”, 
while convulsive, generalised attacks were specified as “grand mal” 
(GROSS, 1992). In the modern era, distinct work and observations 
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were made by John Hughlings Jackson in the 19th century, who 
described epilepsy as caused by paroxysmal, excessive discharge of 
neurons within a localised area that could affect other regions of the 
brain (GROSS, 1992). Also in the 19th century, first successful surgical 
interventions were performed by Victor Horsley, who resected an 
epileptic focus (KANDEL et al., 2000) and also performed first 
surgeries using a famed stereotactic frame (JENSEN et al., 1996). 
Stereotactic interventions were intensely developed later on in the 
Soviet Union (KANDEL, 1990). Finally, the development of 
anticonvulsive medications such as barbiturates as well as 
improvement of the diagnostic tools (mostly concerning the invention 
of electroencephalography) in the 1920s and 1930s has brought the 
epileptology to the current state of medical knowledge (GROSS, 1992; 
KANDEL et al., 2000). 
Currently, epileptic seizures are known to originate in hyperexcitable 
neuronal networks. Moreover, it is recognised that an occurrence of 
an epileptic seizure in a neuronal circuit often increases the likelihood 
of manifestation of subsequent seizures emerging from the same 
circuit. This results from the series of modifications and dysregulatory 
changes called epileptogenesis. The subject of this thesis is to 
understand if and to which extent the epileptogenic process influences 
activation of specific stress-related proteins. 
Heat shock proteins are members of a family of molecules discovered 
in 1962 by an Italian geneticist Ferruccio Ritossa (DE MAIO et al., 
2012) and serve several important functions in the cell. They play a 
pivotal role in activation of the inflammatory cascade (VABULAS et al., 
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2002b; PANDOLFI et al., 2016), which is one of factors contributing to 
initiation and further development of epileptogenic modifications 
(VEZZANI et al., 2002; PITKANEN, 2010; RAVIZZA et al., 2011). 
Better understanding of changes that heat shock proteins undergo 
subsequently to the insult initiating epileptogenesis may be of use in 
context of development of treatment strategies targeting these 
proteins and the metabolic pathways in which they are involved. 
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II.  LITERATURE OVERVIEW 
1. Epilepsy 
1.1. Definition and classification of the disease 
According to the definition of the International League Against 
Epilepsy (ILAE), “epilepsy is a disorder of the brain characterised by 
an enduring predisposition to generate epileptic seizures, and by the 
neurobiological, cognitive, psychological, and social consequences of 
this condition” (ILAE, 2014). This definition of epilepsy requires an 
occurrence of at least one epileptic seizure, and from the practical, 
clinical point of view, an additional high risk of manifestation of another 
epileptic incident, or having at least two unprovoked epileptic seizures 
>24 h apart (FISHER et al., 2014; BERENDT et al., 2015). An epileptic 
seizure is understood as a transient manifestation of signs or 
symptoms resulting from excessive synchronous, usually self-limiting 
epileptic activity of neurons in the brain. They may be objective (loss 
of awareness, stiffening or jerking) or subjective (a rising sensation 
from the abdomen to the chest, a smell of burned rubber or déjà vu in 
humans), as well as motor, autonomic (e.g. dilated pupils, 
hypersalivation, vomiting) or behavioural (e.g. anxiousness, 
restlessness, unexplainable fear reactions, abnormal attention 
seeking etc.) (FISHER et al., 2014; BERENDT et al., 2015; 
DEVINSKY et al., 2018).  
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ILAE classifies seizures into ones of focal, generalised or unknown 
onset, with further subcategorisation into motor or non-motor 
(autonomic or behavioural) seizures and the description of the 
awareness level for the focal type. Focal onset results from abnormal 
neuronal activity arising in a single or multiple localised brain regions 
or in one hemisphere, generalised seizures arise from anomalous 
activity of neurons spread over both hemispheres: Allocation of 
seizures to the unknown type is recommended when available clinical 
and laboratory data cannot fully identify the onset as a focal or a 
generalised class. An epileptic seizure may also start in a localised 
area in the brain and spread afterwards, finally involving both 
hemispheres – this kind of incident is called a focal epileptic seizure 
evolving to become generalised or a focal seizure with secondary 
generalisation (BERENDT et al., 2015; FISHER et al., 2017; 
DEVINSKY et al., 2018). Current veterinary terminology regarding 
epileptic seizures is summarised in Table 1. 
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Terminology Clarification 
Focal epileptic seizure 
An epileptic seizure with clinical 
signs indicating activity, which 
starts in a localised area in the 
brain. It presents with focal 
motor, autonomic or 
behavioural signs alone or in 
combination. 
Generalised epileptic seizure 
An epileptic seizure with clinical 
signs indicating activity 
involving both cerebral 
hemispheres from the start. In 
dogs and cats, the seizure 
presents predominantly as 
immediate tonic-clonic 
convulsions and loss of 
consciousness. Salivation, 
urination and/or defecation 
often also occur during 
convulsions. May also (but 
rarely) present as atonic or 
myoclonic seizures. 
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Focal epileptic seizure evolving 
to become generalised (focal 
seizure with secondary 
generalisation) 
An epileptic seizure, which 
starts in a localised area in the 
brain and spreads subsequently 
to involve both hemispheres. In 
dogs and cats, the seizure 
starts with localised motor, 
autonomic and/or behavioural 
signs rapidly followed by 
convulsions. Salivation, 
urination and/or defecation 
often also occur during 
convulsions. 
Table 1. Veterinary terminology referring to epileptic seizures (modified 
from BERENDT et al. (2015)). 
An epileptic seizure in veterinary medicine terms is usually classified 
as an ictus (seizure activity per se) followed by a postictal phase 
(restoration of the normal brain functionality, clinically demonstrating 
as vocalisation, compulsive locomotion, ataxia, excessive thirst and 
hunger, immediate need to urinate and defecate). In some animals, a 
prodrome might be present – a preictal phase involving changes 
occurring hours to days before a seizure and indicating an upcoming 
incident. Human patients may experience long periods of emotional 
fluctuations; in dogs the prodromal signs usually demonstrate as 
restlessness, anxiousness, aggression or attention-seeking patterns 
(BERENDT et al., 2015) 
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Aetiological classification of the disease in veterinary medicine has 
been suggested by the international veterinary epilepsy task force 
consensus and currently consists of an idiopathic and structural group. 
Idiopathic type involves cases where no structural cerebral pathology 
is suspected. It can either have a proven (genetic epilepsy) or a 
suspected genetic background (suspected genetic epilepsy), or an 
unknown underlying cause with no indication of structural epilepsy 
(idiopathic epilepsy). Structural epilepsy, also known as symptomatic 
epilepsy, is a type of the disease caused by identified cerebral 
pathology. Former cryptogenic epilepsy (where involvement of 
structural brain pathology is possible or probable, nevertheless it 
remains obscure) is currently classified as epilepsy of unknown cause 
(idiopathic epilepsy) (BERENDT et al., 2015). 
1.2. Epidemiology of epilepsy 
Epilepsy is one of the most important neurological diseases in both 
human and veterinary medicine. It is also one of the oldest recognised 
disorders in the world, with written records dating back to 4000 BCE. 
It is estimated that around 65 million people worldwide suffer from 
epilepsy (DEVINSKY et al., 2018; VEZZANI et al., 2019), affecting 4 
to 10 people per 1000, while the proportion increases to 7-15 per 1000 
in low- and middle-income countries (ORGANISATION, 2019). Global 
burden of disease, a metric used commonly by World Health 
Organisation (encompassing mortality, morbidity, injuries and other 
risk factors related to the disease etc.), reaches 0.6% in case of 
epilepsy (ORGANISATION, 2019) and shows a significant decrease 
from 1990 to 2016 worldwide (COLLABOLATORS, 2019). Despite 
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that fact, epilepsy is still an important cause of disability and mortality 
as well as general decline in life quality for human patients. Thus, 
reducing the burden of the disease is one of priorities in treatment 
development. Additionally, epilepsy often correlates with other 
neurological and psychiatric comorbidities, such as cognitive deficits, 
anxiety, depression or autism spectrum disorders (VEZZANI et al., 
2019). 
Epilepsy poses a serious problem also in veterinary practice. With a 
prevalence ranging from 0.55 to 5.7 percent of the canine population, 
it is the most frequent neurological disorder described in dogs 
(LOSCHER et al., 1985; BERENDT et al., 2002; KEARSLEY-FLEET 
et al., 2013; BERENDT et al., 2015; HAMAMOTO et al., 2016; 
URIARTE & MAESTRO SAIZ, 2016). Prevalence in certain breeds is 
higher than in the whole canine population, e.g. in Danish Labrador 
retrievers it reaches 3.1%, whereas prevalence of 1% is described for 
the general population (BERENDT et al., 2002). Some risk factors 
associated with epilepsy of unknown origin include sex and breed, with 
male dogs having significantly higher odds of developing the disease 
than females (KEARSLEY-FLEET et al., 2013). German shepherd 
dogs and border terriers show also high correlation between breed 
and epilepsy of unknown origin. Pugs, boxers, basset hounds and 
border terriers have shown a higher risk of seizure events as 
compared to Labrador retrievers with odds ratio reaching from 1.74 to 
1.96 (ERLEN et al., 2018). Purebred dogs were however not found to 
be at overall higher risk of the disease than crossbred ones 
(KEARSLEY-FLEET et al., 2013). The available literature regarding 
feline epileptic patients remains scarce in comparison to data 
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presented in dogs. However, epileptic seizures pose a common 
neurological manifestation also in cats, with estimated prevalence 
ranging between 0.5 to 3.5% (CHARALAMBOUS et al., 2018). 
1.2.1. Issues with current therapy methods in veterinary 
medicine 
Pharmacoresistance towards anti-epileptic drugs (AEDs) is a 
substantial problem in veterinary medicine, both in clinics and in drug 
research and development. Drug resistant epilepsy is defined in 
human medicine as “a failure of adequate trials of two appropriately 
chosen and used antiepileptic drug schedules (whether as 
monotherapies or in combination) to achieve sustained seizure 
freedom” (KWAN et al., 2010). It is estimated that around one third of 
canine population is pharmacoresistant to standard therapeutic 
measures (PACKER et al., 2014). Data regarding drug resistance in 
cats is much more limited – the problem is however known in clinical 
praxis and in research (BARNES HELLER, 2018). Also a significant 
proportion of human patients (more than 40%, SHARMA et al. (2015)) 
do not respond to any of two to three first line AEDs, despite 
administration in an optimally tailored and monitored regimen. 
Pharmacoresistance seems to correlate with certain features of the 
disease, such as high seizure frequency, febrile seizures prior to 
treatment or early onset of seizures (REMY & BECK, 2006). 
The search for alternative treatment targets in epilepsy is of invaluable 
importance, especially considering disadvantages of standard 
therapy. For example, benzodiazepines are one of most common 
antiepileptic, anxiolytic and sedative hypnotic drugs (ENGEL & 
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PEDLEY, 2008). Their effect results from modulation of γ-
aminobutyric acid(GABA)-evoked currents by activating the 
benzodiazepine recognition site of GABAA receptors. However, drugs 
acting on GABA receptors are known for their loss efficacy over time 
(tolerance), development of dependence and a potential for drug 
abuse (LOSCHER et al., 2004). GABAA receptor subunit composition 
can change over prolonged seizure activity resulting in drug tolerance. 
Moreover, the result of activation of the GABAA receptor depends on 
the state of chloride channels and, as a consequence, on chloride 
homeostasis– changes in expression of chloride ionophores may lead 
to chloride efflux, resulting in gradual depolarisation instead of 
hyperpolarisation of neurons and, by that, leading to excessive 
excitation (POTSCHKA, 2013). In that case, application of GABA 
agonists would increase neuronal excitability instead of decreasing it. 
In human tissue from patients with drug-resistant epilepsy and in 
rodent models of chronic epilepsy, several alterations of sodium 
channel function and expression have been observed. Among 
identified changes, downregulation of accessory subunits, altered 
alpha subunit expression and induction of neonatal forms of the 
channel are known to play a role in granule cells of dentate gyrus as 
well as pyramidal cells of Cornu Ammonis 1 (CA1) and Cornu 
Ammonis 3 (CA3) regions of the hippocampus (REMY & BECK, 2006). 
An additional difficulty in therapy of canine patients by means of the 
most common antiepileptic drugs emerges from the fact that the 
majority of them is either eliminated by dogs more rapidly in 
comparison to humans, or toxicity of the drug remains high in its 
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effective doses (SCHWARTZ-PORSCHE et al., 1985; LOSCHER et 
al., 2004). Half-life sufficient to keep a drug concentration in blood 
effective is present only in few AEDs, i.e. phenobarbital, primidone and 
potassium bromide (FREY & LOSCHER, 1985; POTSCHKA et al., 
2013). Among medications suitable to be applied in treatment of 
canine patients, the most effective in idiopathic epilepsy cases proved 
to be: phenobarbital (administered orally), imepitoin and potassium 
bromide in monotherapy, as well as levetiracetam and zonisamide as 
adjunct AEDs, according to one systematic review of veterinary 
clinical studies (CHARALAMBOUS et al., 2014). The authors however 
stated that a large part of studied articles was of doubtful quality, 
describing non-randomised trials with small group sizes and showing 
a relatively high risk of bias.  
Treatment in feline patients differs substantially from methodology 
used in canines due to divergent safety profiles in the two species. 
There are many therapy guidelines available for epileptic dogs, taking 
into consideration efficacy of different AEDs in this species – such 
guidelines are lacking however in feline neurology (CHARALAMBOUS 
et al., 2018). There is no consensus among veterinary practitioners 
about the exact time point, when the antiepileptic treatment should be 
started – it is suggested not to begin the therapy after a single seizure, 
but after a few seizure occurrences (PAKOZDY et al., 2014). 
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2. Epileptogenesis 
Epileptogenesis is a multifactorial process of development and 
extension of tissue capable of generating spontaneous seizures, 
which results in emergence of an epileptic condition in the first place 
and/or in progression of already established epilepsy. It can either 
result from an external or internal event (epileptogenic insult) or arise 
from genetic background of the disease (PITKANEN, 2010; 
DEVINSKY et al., 2018). The cause may however remain unknown in 
many patients. In temporal lobe epilepsy (TLE) the process begins 
before the first spontaneous seizure and leads to functional alterations 
of a normal brain network toward a higher seizure susceptibility. The 
process as well as frequency and severity of unprovoked incidents can 
progress over weeks in animal models and for years in humans, in the 
end resulting in increased probability of neuronal networks in altered 
brain tissue to generate spontaneous recurrent seizures (SRSs) 
(PITKANEN et al., 2015). 
2.1. Animals models of epileptogenesis 
In vivo animal models are common in the research field of 
epileptology. They play a pivotal role in understanding mechanisms 
underlying ictogenesis (generation of seizures) and epileptogenesis 
(with many of them being common for both processes, e.g. 
neuroinflammation (VEZZANI et al., 2019)), as well as in development 
of anti-epileptic drugs, representing an important link in the chain of 
progress from bench to bedside (LOSCHER, 2011). Essentially, 
animal models used in epilepsy research can be classified either as 
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models of epileptic seizures, or as models of epilepsy (LOSCHER, 
2011). Rodent models of acquired focal epilepsy mostly tend to base 
on brain insults such as status epilepticus (SE), traumatic brain injury, 
stroke, infections and neoplasms (DEVINSKY et al., 2018). Post-
status epilepticus models of temporal lobe epilepsy are often 
considered as possessing the greatest parallels to development and 
progression of the disease in humans (LOSCHER, 2011). Various 
forms of SE used in epileptogenesis research include: injections of 
chemoconvulsants, such as pilocarpine or kainic acid, and direct 
electrical stimulation of brain regions involved in generating seizures, 
e.g. hippocampus or basolateral amygdala (BLA). Depending on the 
model, video electroencephalography (EEG) monitoring after insult 
may reveal no SRSs up to two weeks after status epilepticus (“latency 
period”). Afterwards, initial recurrent seizures tend to be non-
convulsive, with following convulsive, short (tens of seconds) SRSs 
(BERTRAM & CORNETT, 1993; PITKANEN et al., 2015). Frequency 
of unprovoked seizures generally increases with time after insult, and 
they often occur in clusters (WILLIAMS et al., 2009). 
2.1.1. SE-BLA model of epileptogenesis 
In the project underlying this dissertation, brains were collected from 
animals used in another study (WALKER et al., 2016), in which the 
electrical SE-BLA model was implemented. Continuous electrical 
stimulation of BLA proved to provoke a focal, self-sustained status 
epilepticus in rats (MCINTYRE et al., 1982). Based on that finding, a 
protocol leading to a self-conserving SE with subsequent appearance 
of SRSs has been established (BRANDT et al., 2003; BRANDT et al., 
2004). In this model, rats undergo 25-minute electrical stimulation via 
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electrode implanted into BLA, which is interrupted after 4h by a 
diazepam injection. This induces one of three behavioural types of 
self-sustained SE: 
 continuous focal, non-convulsive seizures (type 1) 
 continuous focal, not convulsive SE, repeatedly interrupted 
by occasional generalised seizures (type 2) 
 continuous generalised, convulsive SE (type 3). 
Overall, around 80% of rats develop SRSs afterwards, reaching 
however only up to 33% of spontaneous seizures in animals 
undergoing type 1 SE and more than 90% in the type 2 and type 3 
(BRANDT et al., 2003). These proportions remain stable, regardless 
of the strain and gender of rats. 
2.2. Alterations in brain in the course of 
epileptogenesis 
Epileptogenesis involves many changes in the brain, on both 
structural and morphological level. Additionally, certain genetic and 
epigenetic modifications engaged in epileptogenetic processes had 
been identified in animal models and were validated in human 
patients. All of the changes imply a constant interplay between 
pathogenic and compensatory mechanisms, affecting in the end the 
outcome of epileptogenesis and clinical manifestation of epilepsy. 
2.2.1. Pathological anatomy of epileptogenesis 
To understand pathological changes of the brain anatomy underlying 
the epileptogenic process, one should also consider physiological 
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composition of areas involved in seizure generation and propagation. 
The most relevant regions encompass the hippocampal formation, 
comprising of the hippocampus and the parahippocampal cortex. 
Hippocampus in humans is an elongated structure resembling 
macroscopically a seahorse (hence the name), located deep within 
the medial temporal lobe of the brain. In rodents, the hippocampus is 
a relatively big structure, placed underneath the neocortex. In rats, the 
region is elongated and C-shaped, extending from septal nuclei at the 
rostro-dorso-medial end to the temporal lobe at the caudo-ventro-
lateral end (DESHMUKH & KNIERIM, 2012). The longitudal 
hippocampal axis is thus referred to as the septotemporal axis, while 
the orthogonal one is called the transverse axis. 
In the hippocampus, three separate regions can be distinguished: 
dentate gyrus (DG), cornu ammonis (CA) and subiculum. In DG, 
principal neurons form a granular cell layer, usually U- or V-shaped as 
seen in coronal sections, with dendrites extending into the molecular 
layer, located superficially to the granular cell layer. Traditionally, the 
dorsal part of the granular cell layer is referred to as the upper blade, 
while the ventral one – the lower blade. Between the upper and lower 
blades one can distinguish the polymorphic cell layer, also known as 
the hilus of the dentate gyrus. In the hilus, mossy fibers (axons of the 
principal neurons of the DG) provide their collaterals to form 
connections with glutamergic neurons (mossy cells) and inhibitory 
interneurons. Mossy cells also project back to the granular layer. 
In CA regions, bodies of pyramidal neurons form a distinctive, well-
defined layer (stratum pyramidale). In coronal sections, stratum 
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pyramidale of CA3 begins between the blades of the DG, near to the 
hilar region, and progresses temporally, finally forming an arch-like 
structure and proceeding gently into CA2, followed by CA1 in the 
medial direction. Cells of the pyramidal layer of CA3 are bigger and 
more dispersed than in CA1, with CA2 cells showing morphology 
transitional between the neighbouring regions. A layer located 
superficially to the stratum pyramidale, called stratum oriens, contains 
mainly cell bodies of inhibitory basket cells and dendrites of pyramidal 
neurons. Stratum radiatum, underlying the pyramidal layer, as well as 
neighbouring stratum lacunosum-moleculare and stratum lucidum 
(thin layer located solely in CA3) contain predominantly fibers and 
synapses as well as scarce cell bodies of interneurons. Functionally, 
CA regions can be divided into proximal (located closer to the DG) and 
distal parts (located closer to the subiculum). 
The entorhinal cortex (Ent) is located in the rostral parahippocampal 
gyrus and serves as a junction between the hippocampus and sensory 
cortices. In humans, it comprises Broadmann areas 28 and 34 
(VISMER et al., 2015). It consists of six layers, with cell-rich outer (V 
and VI) and inner (II and III) layers separated by a layer with scarce 
cells (IV). Neurons from layers II and III send major inputs to the DG 
and the subiculum, while layers V and VI receive the feedback from 
CA1 and subiculum (DESHMUKH & KNIERIM, 2012). Ent is 
subdivided into two major parts, the rostro-lateral and the caudo-
medial entorhinal cortex, which differ in their architecture and 
functions. Lateral Ent is organised in patches of neurons surrounded 
by bundles of fibers, while the histology of the medial Ent resembles 
neocortex, with clearly distinguishable laminas and columnar 
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organisation of neurons and fibers (VISMER et al., 2015). Cells 
located laterally in the lateral Ent and dorso-caudally in the medial Ent 
project to septal parts of the hippocampus, while those located 
medially in the lateral Ent and rostro-ventrally in the medial Ent 
connect predominantly with its temporal levels (DESHMUKH & 
KNIERIM, 2012). Ent receives input also from the piriform cortex 
(consisting of around 33% of the total afferents into the Ent) as well as 
from temporal and frontal cortices. The major output of the entorhinal 
cortex reaches the piriform cortex and the hippocampus (VISMER et 
al., 2015). 
The perirhinal cortex (PRh) is located in the parahippocampal gyrus 
and it borders with the entorhinal cortex ventro-laterally. In humans, it 
stretches along the collateral sulcus in the ventro-medial part of the 
temporal lobe, comprising Broadmann areas 35 and 36 (VISMER et 
al., 2015). It is involved in complex visual memory functions, such as 
object recognition and spatial orientation. In human patients with 
temporal lobe epilepsy, it is associated with a phenomenon of déjà vu, 
experienced often at the onset of seizures (MARTIN et al., 2012). PRh 
receives its major input from Ent as well as from the piriform cortex, 
from bordering association areas as well as from other cortical and 
limbic areas, and it projects back to the same regions (VISMER et al., 
2015). Due to its interconnectivity and its strategic location in the 
temporal lobe, it serves as the main interface of sensory inputs 
between the neocortex and the hippocampal formation, relaying 
signals in both directions (WITTER & GROENEWEGEN, 1986). 
The piriform cortex (Pir) is a part of olfactory system, serving mostly 
II. Literature overview  19 
as a processor of olfactory signals and coding memories. It expands 
over the ventro-lateral surface of the forebrain and constitutes of three 
cellular layers, presenting cytoarchitectonics typical for the 
paleocortex (SQUIRE, 2009). The superficial plexiform layer I (Pir1) 
consists of two sublamina: layer Ia, including axons of mitral and tufted 
cells of the olfactory bulb, and layer Ib, located deeper, consisting of 
associative axons from Pir and other cortical areas. Layer II (Pir2), 
located deeper in reference to Pir1, contains cell bodies of most of 
principal neurons of the piriform cortex. Layer III (Pir3) comprises of 
fibres and cell bodies of some pyramidal and multipolar cells 
(SQUIRE, 2009; VISMER et al., 2015). Endopiriform nucleus is a 
structure adjacent to the layer III of the piriform cortex, comprising 
mostly multipolar cells and sharing many properties with the rest of the 
region, such as excitatory discharges, hyperexcitability and fast signal 
propagation (VISMER et al., 2015). 
The piriform cortex projects directly to Ent, PRh and to the amygdala, 
there are however significant differences in the connectivity between 
the rostral and caudal portion of Pir. Local GABAergic circuitry is more 
prominent in the caudal subregion, gradually decreasing in the rostral 
direction, becoming the least prominent in the area tempestas (AT) 
(VISMER et al., 2015). This ventro-rostral portion of Pir constitutes a 
histologically and functionally distinct region, highly responsive to 
chemoconvulsants. AT shows a lower density of GABAergic axons as 
well as decreased number of interneurons as compared with the rest 
of the piriform cortex. A unilateral injection of picomole amounts of 
GABA receptors antagonists or glutamate receptor agonists into this 
locus can trigger generalised seizures (PIREDDA & GALE, 1985). 
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Connectivity of the hippocampal formation in relation to 
epileptogenesis 
A transverse section of the hippocampus shows the classical 
hippocampal connectivity of the “trisynaptic loop”. This pathway has 
originally been described by Santiago Ramón y Cajal (RAMÓN Y 
CAJAL, 1995). It serves as a basic model of hippocampal circuitry. 
Briefly, neurons of the layer II of the entorhinal cortex (Ent) provide the 
major input from the cortex to the hippocampus, with the most 
pronounced pathway reaching the dentate gyrus (DG) region, forming 
the first synapse of the loop with dendrites in the molecular layer of 
the DG. The DG projects axons to the cornu ammonis 3 region (CA3) 
via the mossy fibers pathway (second synapse), and finally, CA3 
projections reach cornu ammonis 1 (CA1) via the Schaffer collateral 
pathway (third synapse). Finally, CA1 projects back to the Ent, 
finishing the circuit (DESHMUKH & KNIERIM, 2012). Proximal CA3 
neuron send more projections to distal CA1 cells and distal CA3 
neurons preferably connect to the proximal part of the CA1 
(DESHMUKH & KNIERIM, 2012). 
A basic theorem in epileptology states that abnormal neuronal activity 
in particularly vulnerable circuits can cause modifications leading to 
permanently enhanced neuronal excitability (OSWALD STEWARD, 
2001). Pyramidal cells, principal neurons of regions described above, 
appear as complex spiking cells in extracellular recordings, meaning 
they are able to generate a burst of action potentials separated by 
short interspike intervals (DESHMUKH & KNIERIM, 2012). Such 
bursting may be a mechanism leading to an increase of downstream 
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excitability by summating the excitatory postsynaptic potentials 
(EPSPs) in subsequent neurons. Repeated high frequency excitation 
of neighbouring cells is also a basis of long-term potentiation (LTP), 
underlying the mechanisms of hippocampal plasticity (DESHMUKH & 
KNIERIM, 2012). Repeated intense synaptic activation leads however 
to abnormally increased neuronal excitability, recruitment of more 
neurons into the circuitry and finally, to construction of a primary focus 
able to exhibit independent and spontaneous epileptiform discharges 
(OSWALD STEWARD, 2001). Thus, epileptogenesis heavily relies on 
synaptic plasticity in the described limbic and cortical regions, and may 
be induced on all levels of this circuitry, particularly prone to 
generating and propagating ictal discharges. 
2.2.2. Histopathology and pathophysiology of 
epileptogenesis 
Alterations of neuronal cells 
One of the most common and characteristic histological changes in 
the temporal lobe epilepsy includes hippocampal sclerosis with 
neuronal cell loss (predominantly in the pyramidal layer of the Cornu 
Ammonis region) and growth of granule cell axons (mossy fibre 
sprouting). The axonal outgrowth occurs predominantly into the inner 
molecular layer and the polymorphic layer (hilus) of the dentate gyrus. 
Mossy fibres serve de novo excitatory positive feedback loops with 
granule cells, contributing to increased excitability in neuronal circuits. 
Mossy fibre sprouting is however not necessary for the process of 
epileptogenesis and blocking the sprouting does not imply reduction 
of seizure occurrence (SANTHAKUMAR et al., 2005; BUCKMASTER, 
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2014). Alternative hypotheses suggest that some deviant mossy fibres 
may innervate inhibitory basket cells in the granular cell layer 
(SLOVITER et al., 2006) or that dentate granule cell become 
GABAergic after repeated seizures (MODY, 2002), supporting the role 
of the new outgrowing axons in the recurrent inhibitory circuits. Mossy 
fibre sprouting is driven by different stimuli, among which 
degeneration of excitatory granular cells and loss of inhibitory 
GABAergic and neuropeptidergic interneurons in the hilus seem the 
most likely. Additionally, the axonal outgrowth of mossy cells can be 
promoted by multiple factors, e.g. exposure to neuromodulin, brain-
derived neurotrophic factor, proteins of the extracellular matrix and 
mammalian target of rapamycin (mTOR) (DEVINSKY et al., 2018). In 
fact, rapamycin, an mTOR inhibitor, suppresses mossy fibre sprouting 
without influencing seizure frequency in a mouse model of TLE 
(BUCKMASTER & LEW, 2011). It is probable that cells of different age 
are being influenced by different mediators, making them more or less 
responsive to them and in the end, leading to variable contributions to 
the process of reconstructing neuronal circuits after the insult 
(DANZER, 2017). 
Neurogenesis, persistent in adult mammals, especially in the 
subgranular zone of the hippocampal dentate gyrus and the 
subventricular zone (SVZ) of the forebrain lateral ventricles, is also 
heavily influenced by epileptic brain activity and can contribute to the 
process of epileptogenesis as a whole (PARENT & KRON, 2012). In 
the rat pilocarpine model of mesial temporal lobe epilepsy, 
neurogenesis is increased even 5-10 fold within weeks following 
status epilepticus both in the SVZ and in the subgranular zone of the 
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dentate gyrus (PARENT & KRON, 2012). Approximately 3-4 weeks 
after SE, proliferation rates return back to the baseline levels and they 
decrease below the baseline in the chronic phase of the TLE. Many 
novel cells tend to migrate into the hilus or the molecular layer instead 
into the granule cell layer of the dentate gyrus, creating a pool of 
ectopic granular cells (PARENT & KRON, 2012). Histopathologically 
it can be demonstrated as granular cell dispersion, usually defined as 
granule cell layer thicker than 10 cells (THOM, 2014). 
Alterations in glial cells 
Many morphological changes occurring in glial cells are also attributed 
to epileptogenesis. Abnormal glia, glial scars and tumours are 
frequent findings in epileptic foci in human patients and in 
experimental epilepsy models (DEVINSKY et al., 2013). Glia can 
promote epileptogenesis by changes in the milieu of epileptic foci 
promoting hyperexcitability (reactive astrocytosis) and inflammation 
(microglia activation). 
Reactive astrogliosis occurs in the epileptic focus, consisting of 
proliferation as well as morphological and functional changes of those 
glial cells. Astrocytes regulate the flow of K+ and water molecules 
between cells and extracellular space in the brain, supervising the 
changes in volume of the extracellular matrix. Shrinking the 
extracellular space promotes excitability by increasing concentrations 
of extracellular potassium ions and conceivably by intensifying 
ephaptic (non-synaptic) contact between neurons (DEVINSKY et al., 
2013). In epilepsy, aquaporin 4 channels present on the astrocytes 
undergo redistribution and enhance water entry into the neuropil, while 
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lessening water transport into capillaries. At the same time, 
expression of inwardly rectifying potassium (Kir) 4.1 channel is 
decreased, leading to higher local extracellular K+ concentrations, and 
predisposing to hyperexcitability (DEVINSKY et al., 2013; DEVINSKY 
et al., 2018). Reactive astrocytes show also some changes in their 
enzymatic composition: increased activity of adenosine kinase 
(regulating levels of adenosine by its conversion into 5’-adenosine 
monophosphate) was demonstrated, lowering in the consequence 
concentrations of inhibitory adenosine, while glutamine synthetase, 
converting glutamate to glutamine (used later in synthesis of GABA), 
demonstrates decreased activity, disrupting the balance of glutamate 
and GABA in neurons. Additionally, in some TLE patients, reduced 
expression of astroglial glutamate transporters was observed (SARAC 
et al., 2009). Thus, impaired glutamate intake may contribute to 
neuronal excitability in epilepsy. Furthermore, excessive release of 
gliotransmitters in activated astrocytes and downregulation of gap 
junction connexins should be considered while assessing a role of 
astrocytosis in promoting seizure activity (DEVINSKY et al., 2018). 
Microglia are immunologically competent cells present in the central 
nervous system. They actively scan the brain and spinal cord, interact 
with neurons and modulate neuro- and gliotransmission (EYO et al., 
2017). Their activation is detected very early (within 5-10 minutes) 
following acute neuronal hyperactivity triggered by activation of N-
methyl-D-aspartate (NMDA) receptors in vivo (EYO et al., 2014). 
Microglia can be activated by many types of molecules: 
neurotransmitters (released by living hyperactive cells or damaged 
cells), damage-associated molecule pattern particles (DAMPs), e.g. 
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adenosine triphosphate (ATP) or  high mobility group box 1 (HMGB1); 
pathogen-associated molecular pattern molecules (PAMPs), e.g. 
lipopolysaccharide (LPS); molecules originating from blood (EYO et 
al., 2014; DEVINSKY et al., 2018). The role of microglia is implied in 
epilepsy-associated neurodegeneration as well as in abnormal 
neurogenesis following the status epilepticus (EYO et al., 2017). 
Bidirectional communication between migroglia and neurons is 
tightened by neuronal release of the chemokine fractalkine, activating 
microglial CXC-chemokine receptor 1, affecting neurogenesis, 
neuronal survival and synaptic plasticity (EYO et al., 2017; DEVINSKY 
et al., 2018). Activated glial cells, both microglia and astroglia, release 
DAMPs, cytokines, e.g. interleukin-1β (IL-1β) or tumour necrosis 
factor (TNF), and chemokines, contributing to epileptogenesis by 
promoting neuronal hyperexcitability (VEZZANI et al., 2011a). Studies 
using minocycline, a potent microglia inhibitor, have shown a 
protective effect against seizures in rodent SE models and in human 
patients, suggesting a pro-convulsive role of activated microglia (EYO 
et al., 2017). Similarly, expression of markers of M1-polarised cells 
(expressing pro-inflammatory cytokines and driving infiltration of cells) 
is commonly upregulated in an acute post-SE phase, which may signal 
their role in epileptogenesis. However, one should not forget the 
importance of M2-polarised population of microglia, acting in 
restorative and neuroprotective manner, promoting phagocytosis of 
debris and expression of enzymes associated with cellular integrity 
and scaffolding, as well as anti-inflammatory cytokines, e.g. 
interleukin-4 and interleukin-10 (BENSON et al., 2015). Henceforth, 
microglia can have both pathogenic and reparative functions, and 
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would require selective inhibition or modulation of their state in case 
of pharmacological intervention. 
Cytokines and chemokines released from activated glial cells can be 
the cause of blood vessel inflammation, leading to dysfunction of the 
blood-brain barrier (BBB). BBB dysfunction is a common finding in 
acquired and structural epilepsies in animal models and in patients 
and it is associated with development of the disease in rodent models 
(DEVINSKY et al., 2018). Increased permeability of the BBB leads to 
extravasation of many blood components, such as albumin and 
macrophages, contributing to local inflammation (VAN VLIET et al., 
2016; BANKSTAHL et al., 2018). Extravasated serum albumin 
activates a transforming growth factor beta (TGF-β) receptor and 
mediates activation of a signalling cascade leading to upregulation of 
transcription of inflammatory genes in glia and, in consequence, to 
local inflammation. It also results in decreased expression of Kir 4.1 
potassium channels and glutamate transporters present in astroglial 
cells, facilitating neuronal hyperexcitability by modifying ionic and 
neurotransmitter composition of the extracellular matrix (DEVINSKY 
et al., 2013). Overexpression of TGF-β has been also demonstrated 
to reinforce neurogenesis (MATHIEU et al., 2010). 
Besides, epileptogenesis involves several genetic and epigenetic 
modifications. Changes in gene expression, both turn-in and turn-off, 
may underlie evolving pathology, such as gliosis, neuroinflammation, 
ion channel and neurotransmitter receptors expression or processes 
plasticity (HENSHALL & KOBOW, 2015). Some of transcriptional 
pathways involved in cell cycle and cell death like the Janus kinase or 
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signal transducers and activators of transcriptions are activated during 
epileptogenesis and their inhibition lowers severity of epileptic 
seizures in a rat model (DEVINSKY et al., 2018). Epigenetic 
mechanisms active in the course of the epileptogenic process include: 
 alterations of DNA methylation (hypomethylation occurring in 
the acute post-insult phase and hypermethylation present in 
the chronic phase), 
 histone acetylation and phosphorylation (e.g. valproate, being 
an inhibitor of histone deacetylase, leads to reduction of 
abnormal neurogenesis in the dentate gyrus) 
 microRNA expression (injection of synthetic mimic of miRNA-
146a impairs signal transduction of IL-1β receptor/Toll-like 
receptor 4 neuroinflammatory pathway, strongly inhibiting 
epileptogenesis) (HENSHALL & KOBOW, 2015; IORI et al., 
2017; DEVINSKY et al., 2018). 
Other molecular mechanisms promoting epileptogenesis involve 
deficiency of neuropeptides, neurosteroids, sphingosine 1-phosphate 
receptors and erythropoietin, which are speculated to contribute to 
neuronal hyperexcitability (DEVINSKY et al., 2018). 
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3. Role of neuroinflammation in 
epileptogenesis 
Inflammation is a dynamic process comprising of production and 
release of pro-inflammatory mediators as well as anti-inflammatory 
molecules in response to harmful stimuli or immune stimulation. The 
inflammatory response is a defence mechanism that evolved to 
protect higher organisms from infection and injury. Inflammatory 
molecules are generated by specialised, immunocompetent cells, 
either residing in tissue or circulating with blood. Mechanisms of both 
innate and adaptive immunity are involved in activation of 
inflammation. The innate immune system is characterised by a non-
specific and prompt response, involving leukocytes (granulocytes, 
natural killer cells), myelomonocytic cells (monocytes, macrophages 
and microglia) and dendritic cells. The adaptive immunity gets 
triggered in response to innate immunity activation, and recognises 
specific non-self-antigens. Lymphocytes B and T get stimulated by 
dendritic cells, macrophages and microglia in order to commence a 
humoral (antibody production) or cellular immune response (VEZZANI 
et al., 2011b). 
Due to presence of the blood-brain barrier and lack of lymphatic 
drainage in traditional terms, the central nervous system is 
conventionally viewed as an immunologically privileged structure. 
Immune privilege is a concept concerning protection of certain vital 
organs, like the brain or the eye, from destructive influences of 
inflammation directed against pathogens (HONG & VAN KAER, 
1999). However, both innate and adaptive immune responses are 
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effectively mobilised in the brain. Microglia, astrocytes and neurons as 
well as endothelial cells and extravasating circulating 
immunocompetent cells are able to produce molecules of 
inflammatory cascades. Inflammatory response can be evoked both 
in infectious and sterile conditions, the latter being induced in 
response to tissue injury or exposed self-antigens (VEZZANI et al., 
2011b; VEZZANI et al., 2015; VEZZANI et al., 2016). 
There is an extensive clinical evidence that pathological conditions of 
the immune system may promote seizures and epilepsy (VEZZANI et 
al., 2019). Autoimmune disorders, such as systemic lupus, multiple 
sclerosis and paraneoplastic syndromes can be a cause of recurrent 
seizures (VEZZANI et al., 2011b). Fever, being one of the main 
symptoms of inflammation, which exacerbates pro-inflammatory 
responses, can commonly induce seizures, especially in children 
(DUBE et al., 2007). Increased neuronal activity can evoke an 
inflammatory response also in absence of other pro-inflammatory 
stimuli – it is then referred to as neurogenic inflammation. Firstly 
described for peripheral nervous system, it is also known to be 
activated by neuronal hyperexcitability during seizures in the central 
nervous system (VEZZANI et al., 2019). In rodent models, status 
epilepticus triggers an immediate increase of pro-inflammatory 
cytokines in brain regions involved in seizure generation and 
propagation, predominantly described in activated astrocytes and 
microglia (VEZZANI et al., 2011b).  
Cytokines and other molecules synthesised as the consequence of 
pro-inflammatory cascade activation in the CNS may affect excitability 
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of neurons as well as the degree of neurogenesis and 
neurodegeneration. Cyclooxygenase-2 (COX-2) is an enzyme 
catalysing the first step in the formation of prostanoids, involved in 
many of physiological and pathophysiological processes 
(ALEXANIAN & SOROKIN, 2017). It is expressed constitutively in 
hippocampal neurons and is activated shortly after a seizure. Several 
prostaglandins, the products of the cascade initiated by COX-2, play 
a role in long-time potentiation of the synapse of the perforant path 
(between axons from the entorhinal cortex and dendrites of granule 
cell layer of the dentate gyrus), which is a crucial connection for 
propagation of seizure activity in the brain (VEZZANI et al., 2013b). 
Selective COX-2 inhibition leads to significant reduction of membrane 
excitability in dendrites and in the cell soma, while application of 
prostaglandin E enhances firing frequency and excitatory postsynaptic 
potential amplitude in excitatory neurons in CA1 (CHEN & BAZAN, 
2005; VEZZANI et al., 2013b). Administration of the non-steroidal anti-
inflammatory drug celecoxib, a selective inhibitor of COX-2, to 
neonatal rats in kainic acid SE model, showed neuroprotective effects 
due to inhibition of the pro-inflammatory cascade (MORALES-SOSA 
et al., 2018). Selective COX-2 inhibitors applied after SE also proved 
to lower the number of proliferating cells in the dentate gyrus 
(VEZZANI et al., 2013b). 
Glia-mediated neuroinflammation can serve as a promoter of icto- and 
epileptogenesis, particularly if physiological servomechanisms fail to 
limit the process. Chronic uncontrolled glial activation leads to 
excessive release of pro-inflammatory mediators, damage to the 
blood-brain barrier and following extravasation of albumin and other 
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blood components, and to disturbances in ionic homeostasis and 
imbalance of neurotransmitters, which can affect seizure 
development. Chronically activated astrocytes form a glial scar, 
having both advantageous and detrimental impact on pathologically 
changed brain tissue. A scar can limit exposure of neurons to stress 
factors and restrict migration of activated immune cells. On the other 
hand, it impairs axonal regeneration and restoration of normal 
neuronal circuits (DEVINSKY et al., 2013). 
3.1. Toll-like receptor signalling in epilepsy 
Activated glial cells release inflammatory molecules acting either in 
autocrine or paracrine manner, inducing transcriptional and post-
transcriptional signalling in themselves or in nearby cells. One of the 
most crucial pathways, involved in the initiation of tissue inflammation 
by activating cells of the innate immunity, is the interleukin-1 
receptor/toll-like receptor (IL-1R/TLR) signalling track. The cascade is 
initiated by activation of members of a superfamily of 24 
transmembrane receptors, all of which share a cytosolic 
toll/interleukin-1 receptor (TIR) domain (VEZZANI et al., 2011a). The 
superfamily consists of the IL-1R family and the TLR family, the latter 
being in the scope of this dissertation. 
Toll-like receptors (TLRs) are a key component of the innate immune 
system. The group consists of eleven [in humans; thirteen in mice (YU 
et al., 2010)] evolutionarily conserved proteins belonging to the pattern 
recognition receptors family. The receptors are responsible for 
recognition of both pathogen-associated and damage-associated 
32 
molecular pattern molecules (PAMPs and DAMPs), meaning they 
recognise highly conserved motifs in pathogens and in non-infectious 
endogenous compounds (JANSSENS & BEYAERT, 2003; VAURE & 
LIU, 2014). TLRs are located in a membrane as well as in some 
intracellular compartments like endoplasmic reticulum (ER) and 
lysosomes of innate immune cells (e.g. dendritic cells and 
macrophages) and in non-immunocompetent cells (e.g. fibroblasts 
and epithelial cells). They are glycoproteins with an extracellular 
leucine-rich repeat domain, which is involved in antigen recognition, 
and an intracellular TIR-like domain, a protein-protein interaction 
module, necessary for signal transduction (JANSSENS & BEYAERT, 
2003; KAWASAKI & KAWAI, 2014; VAURE & LIU, 2014). 
Toll-like receptor 4 (TLR4) is located on the cell surface. It specifically 
recognises lipopolysaccharide (LPS), an antigen found in an outer 
layer of Gram-negative bacteria, as well as several other exogenous 
PAMPs (e.g. lipoteichoic acids of Gram-positive bacteria). 
Additionally, it binds also endogenous DAMPs, such as heat shock 
proteins and S100 proteins, normally expressed in the cytoplasm and 
cell organelles, but released into the extracellular matrix during tissue 
injury and thus available for binding with receptors on the cell surface 
(VAURE & LIU, 2014). 
TLR4 in rats shows 61% of amino acid similarity with a human receptor 
in the extracellular domain, 68% similarity in the transmembrane 
domain, and 92% in the proximal and 38% in the distal cytoplasmic 
region. Canine TLR4 shows 70-77% overall similarity to human 
nucleotide and amino acid sequences, being also highly similar to 
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other mammalian TLR4 sequences (VAURE & LIU, 2014). It shows a 
relatively high conservation of the receptor’s structure, especially in 
the intracellular domain. Nevertheless, the spectrum of agonists and 
antagonists of TLR4 varies significantly across species, resulting in 
diverse functionality and expression pattern of the same receptor. In 
the human central nervous system, TLR4 is expressed predominantly 
by astrocytes and microglia, while in rats it was observed solely in 
microglial cells (VAURE & LIU, 2014). 
After binding to a ligand (Fig. 1), TLR4 undergoes dimerisation leading 
to induction of one of the two major pathways described for that 
receptor: TIR adapter protein – myeloid differentiation factor 88 
(TIRAP – MyD88) cascade, in which IL-1R associated kinases 4, 1 
and 2 (IRAK4, IRAK1, IRAK2) are released from MyD88. IRAK4 is 
activated initially and regulates release of nuclear factor κB (NF-κB) 
and mitogen-activated protein kinases (MAPK). Following activation of 
IRAK1 and IRAK2 amplifies the signal from NF-κB and MAPK. The 
MyD88-dependent pathway signalling leads to induction of 
transcription of many genes and the consequent synthesis of pro-
inflammatory molecules (JANSSENS & BEYAERT, 2003; KAWAI & 
AKIRA, 2010; VEZZANI et al., 2011a; KAWASAKI & KAWAI, 2014). 
TLR4 can also signal using a MyD88-independent pathway involving 
TIR-domain-containing adapter-inducing interferon-β (TRIF). The 
signal from TLR4 to TRIF is transducted by TRIF-related adaptor 
molecule (TRAM) and it results in activation of interferon regulatory 
factor 3 (IRF-3), supervising synthesis of interferons α and β (KAWAI 
& AKIRA, 2010; VEZZANI et al., 2011a; KAWASAKI & KAWAI, 2014). 
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Several negative regulators of TLR signalling have been identified. 
They act on multiple levels in the cascade initiated by TLR activation 
and involve ubiquitin ligases and deubiquitinases, transcriptional 
regulators, molecules controlling mRNA stability as well as miRNA 
(KAWAI & AKIRA, 2010). The negative regulation of TLR-evoked 
pathways is important for suppressing inflammation and harmful 
consequences of chronic inflammatory processes for the tissue. 
 
Figure 1. Pro-inflammatory TLR4 signalling. TLR4, located on the cell surface, 
initiates signalling to the two major downstream adaptor proteins, MyD88 and 
TRIF. TIRAP mediates the signal from TLR4 to MyD88, and TRAM transfers 
the signal from TLR4 to TRIF. The subsequent signalling cascades lead to the 
upregulation of transcription of genes encoding pro-inflammatory cytokines 
and to exacerbation of the inflammatory process. 
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Balanced production of inflammatory molecules supports key roles of 
the immune system like combating infections or controlling tumour cell 
growth. Nevertheless, overstimulation of TLR4 can lead to severe 
pathologies, including sepsis, autoimmune diseases as well as acute 
and chronic neurological disorders, also epilepsy (MAROSO et al., 
2010; MAROSO et al., 2011; VEZZANI et al., 2011a; ZHANG et al., 
2013b). Reciprocally, tissue injuries and seizures may cause 
upregulation of expression of TLR4, which is present on brain cells at 
low levels in physiological conditions (MAROSO et al., 2010; 
VEZZANI et al., 2013b). Single elements of TLR4-induced cascade 
are upregulated in neurons and glial cells in tissue from epileptic 
human patients and in mice models (WANG et al., 2018a). 
Exogenous application of LPS into rat cerebral cortex increased 
excitability of local neurons by tripling evoked field potential 
amplitudes and producing focal epileptiform discharges. This activity 
commenced within 10 minutes after LPS administration and recurred 
every 1-2 minutes for 30 minutes of the recording time. These effects 
were prevented by pre-application of IL-1R inhibitors, which implicates 
a role of IL-1β released from activated microglia and astrocytes, and 
supports a critical part of innate immunity mechanisms in ictogenesis 
(RODGERS et al., 2009). The activation of TLR4 by LPS also exerts 
long-term effects on neuronal excitability – LPS injection in rats within 
two post-natal weeks decreased seizure threshold in adult animals 
exposed to various pro-convulsive compounds in their adulthood 
(RIAZI et al., 2010). The effect extends also onto glial cells – TLR4 
stimulation causes disruption of gap junctions, leading to uncoupling 
of astroglial cells, impaired K+ buffering and generation of 
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spontaneous seizures (BEDNER et al., 2015). Astrocytic TLR4 
pathways prove to regulate postnatal development of excitatory 
synapses in hippocampus (SHEN et al., 2016). TLR4-deficient mice 
developed less severe epilepsy following SE (VEZZANI et al., 2013a). 
This evidence demonstrates that brain inflammation erupted in early 
stages of life can lead to long-term alterations in neuronal excitability, 
and trigger and/or promote epileptogenic modifications as the 
consequence. 
Pharmacological or genetic interference with the IL-1R/TLR pathway 
before a seizure episode provides further evidence of its engagement 
in epileptogenesis and highlights the possibility of modulation of the 
outcome of the epileptogenic process. TLR4 knock out mice were 
protected from detrimental effects of LPS peripheral injection on 
astrocytes (BEDNER et al., 2015). Exogenous application of a 
synthetic mimic of miRNA-146a impaired IL-1R/TLR signal 
transduction and reduced neuronal excitability and acute seizures as 
well as diminished disease progression and decreased chronic 
spontaneous recurrent seizures in a mouse model of acquired 
epilepsy (IORI et al., 2017). 
3.2. Endogenous ligands of TLR4 
TLRs are responsible for PAMPs recognition, they respond however, 
in addition to microbial ligands, also to a number of endogenous 
molecules, which serve as potent activators of inflammatory 
responses. They are capable of activating not only the innate immune 
system, but also the adaptive immune response by induction of 
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costimulatory proteins present in antigen-presenting cells (TSAN & 
GAO, 2004). Damage-associated molecular patterns (also referred to 
as alarmins or danger signals) are molecules constitutively expressed 
in all cell compartments where they play a role in cell homeostasis. 
When present in the extracellular environment however, they act as 
ligands for pattern-recognition receptors, such as TLRs, leading to 
activation of pro-inflammatory processes. Since they proved to be 
released by cells undergoing necrosis, but not the apoptotic ones, they 
were originally associated solely with cell death. DAMPs can be 
however also secreted by stressed living cells or expressed 
constitutively in the extracellular matrix and cleaved as the result of 
injury or inflammation (SCAFFIDI et al., 2002; KAWAI & AKIRA, 2010; 
VENEREAU et al., 2015; PANDOLFI et al., 2016). 
The group of DAMPs serving as ligands for TLR4 includes:  
 polysaccharides and degradation products of proteoglycan 
(biglycan, CD138, soluble hyaluronian, heparin sulphate), 
 phospholipids (OxPAPC), 
 small organic molecules (monosodium urate crystals), 
 proteins and peptides (α-crystallin A chain, β-defensin 2, 
endoplasmin, fibrinogen, fibronectin, HMGB1, many members 
of the heat shock protein superfamily, resistin, S100 proteins, 
surfactant protein A and tenascin-C) (TSAN & GAO, 2004; 
PARK et al., 2006; KAWAI & AKIRA, 2010; KAWASAKI & 
KAWAI, 2014). 
High mobility group box 1 (HMGB1) protein is among the best-
characterised DAMPs. It is a highly conserved and abundant DNA 
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chaperone. It interacts with DNA and histones to transiently and 
reversibly modify chromatin structure, facilitating nucleosome 
formation and regulating key nuclear processes, i.e. transcription, 
replication and DNA repair (MAGNA & PISETSKY, 2014; RAVIZZA et 
al., 2018). During inflammation, it is translocated from cells into the 
extracellular space and recognised by TLR4. HMGB1 plays an 
important role in acute pathological conditions (e.g. sepsis, shock), but 
also in several autoimmune and inflammatory disorders, such as 
rheumatoid arthritis, systemic lupus erythematosus, myositis, 
scleroderma and ankyloses spondylitis (MAGNA & PISETSKY, 2014). 
It also proved to be translocated from nucleus to cytoplasm in neuronal 
and glial cells at sites of local damage in animal models of acquired 
epilepsy within one hour from the seizure onset (MAROSO et al., 
2010; RAVIZZA et al., 2018). HMGB1 release accelerates the seizure 
precipitation evoked by chemoconvulsants and exacerbates their 
number and severity. At the same time, antagonists of HMGB1 and 
TLR4 retard seizure onset and decrease recurrence of acute and 
chronic seizures (MAROSO et al., 2010). The activation of HMGB1-
TLR4 signalling has also been demonstrated in human tissue from 
epileptic patients resected during surgery, indicating a role of this 
pathway in the disease in humans (MAROSO et al., 2010; RAVIZZA 
et al., 2018). Administration of therapeutic anti-HMGB1 monoclonal 
antibodies in mice models of both acute and chronic epilepsy 
attenuated severity of kindling- and kainic acid-induced seizures, but 
also reduced the number of spontaneous recurrent general and focal 
seizures. (SOBIESKI & CHRISTIAN, 2017; ZHAO et al., 2017). The 
example of HMGB1 clearly indicates a role of DAMP-related TLR 
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signalling in epileptogenesis. Therefore, examination of other TLR 
ligands and their influence on epileptogenic processes is of great 
interest concerning the search for possible targets for therapeutic 
intervention. Based on an extensive proteomics study (WALKER et 
al., 2016) as well as on their physiological and pathological relevance, 
three members of heat shock protein family, a group of TLR ligands, 
were selected for in-depth investigation during this study. 
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4. Heat shock proteins and their relation 
to epilepsy 
4.1. Heat shock protein family description 
Heat shock proteins (HSPs) constitute a class of potent TLR ligands 
(ASEA et al., 2002; TSAN & GAO, 2004; YU et al., 2010). HSPs 
comprise a heterogeneous group of molecules with highly conserved 
structure, expressed ubiquitously in cells of the body and present in 
all cell compartments (nucleus, cytosol, mitochondria, chloroplasts, 
endoplasmic reticulum). They appear in all domains of life: archaea, 
eubacteria and eukaryotes. Some of them are expressed 
constitutively in order to promote proper folding and assembling of 
proteins, while most of them are produced in response to cellular 
stress, including oxidative stress, hyperthermia, ischemic injury and 
neuronal excitability, which result in accumulation of denatured and 
misfolded proteins (BENARROCH, 2011). Polypeptides folded 
improperly tend to form aggregates, which is a prominent 
characteristic of several neurodegenerative diseases, like Alzheimer 
disease, Parkinson disease and Huntington disease (ASEA, 2008; 
BENARROCH, 2011; ASEA, 2016). HSPs provide a first line of 
defence against accumulation of misfolded proteins (serving as so-
called chaperones) as well as execute other neuroprotective effects, 
e.g. inhibition of apoptosis, protection of cytoskeletal structures and 
immune modulation in stress conditions (BENARROCH, 2011). 
Traditionally, HSPs are classified according to their molecular weight 
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in kilodaltons (kDa) into several major classes: HSP110, HSP90, 
HSP70, HSP60, HSP40 and small HSPs, with molecular weight 
smaller than 40 kDa (KAMPINGA et al., 2009; BENARROCH, 2011). 
This nomenclature however can often be confusing, since a lot of HSP 
family members do not include “heat shock” in their commonly used 
names. Moreover, the number of members of particular classes is 
gradually increasing (KAMPINGA et al., 2009). For the purpose of this 
monography, the modified nomenclature suggested in the guideline 
by KAMPINGA et al. (2009) will be implemented: 
 Members of the heat shock protein family of 70 kDa 
molecular weight (usually referred to as HSP70) will be 
specified as HSPA, in particular: 
o Products of genes HSPA1A and HSPA1B, differing 
by two amino acids, are considered fully 
interchangeable proteins. In the suggested 
nomenclature they are referred to as HSPA1A/1B, in 
literature they are also known as HSP72, HSP70i 
and HSP70. For the purpose of clarity, this protein of 
interest will be referred to as HSPA1. 
o Product of HSPA8 gene is a cognate of HSPA1 
expressed constitutively and designated in literature 
as heat shock cognate 70 kDa (HSC70), HSP71 and 
HSP73. In this publication, the name HSPA8 will be 
used. 
o Product of HSPA5 gene is a heat shock protein 
localised in the endoplasmic reticulum. Other 
common names include 78 kDa glucose regulated 
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protein (GRP78) and binging immunoglobulin protein 
(BiP). It will be referred to as HSPA5. 
 Members of the heat shock protein family of 110 kDa 
molecular weight (so-called HSP110), a group showing a 
high homology to HSPA, will be specified as HSPH: 
o Product of HSPH4 gene, a compartment-specific 
chaperone located in the endoplasmic reticulum, is 
commonly referred to as hypoxia upregulated protein 
1 (HYOU1), 170 kDa glucose-regulated protein 
(GRP170) or 150 kDa oxygen-regulated protein 
(ORP150). In this monography, the name HSPH4 
will be used. 
 Members of the heat shock protein family of 90 kDa 
molecular weight (HSP90), will be referred to as HSPC. 
 Members of the heat shock protein family of 40 kDa 
molecular weight (HSP40), will be referred to as DNAJ. 
 Heat shock proteins of molecular weight smaller than 40 kDa 
will be referred to as HSPB or small HSPs (KAMPINGA et 
al., 2009; UNIPROT, 2019a, 2019b, 2019c). 
4.2. Role of HSPA1 in the cell and in TLR signalling 
According to the definition from 1986, HSPA (HSP70) family includes 
“proteins whose synthesis is stimulated by stress, and whose genes 
contain a marker nucleotide block—heat shock consensus element —
CT-GAA-TTC-AG” (MALYSHEV, 2013). It includes at least thirteen 
isoforms, both constitutive and inducible, expressed in all cell 
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compartments as well outside of the cell (KAMPINGA et al., 2009; 
TURTURICI et al., 2011). In humans, they account for 2% of all protein 
mass under stress conditions (TURTURICI et al., 2011; ZUIDERWEG 
et al., 2013). HSPA8 and HSPA5 as well as mitochondrial HSPA9 are 
expressed abundantly under normal conditions. HSPA1 levels are 
however induced in response to different stress stimuli (TURTURICI 
et al., 2011). The synthesis of HSPA1 in a cell is controlled 
transcriptionally – the process of HSPA1 transcription is strongly 
induced immediately after heat shock, whereas the translation rate 
remains almost unchanged, meaning the protein synthesis rate 
depends predominantly on the transcription rate of the HSPA1A/1B 
gene (GERNER et al., 2002). Biological half-life of HSPA1 was 
estimated for 18.1 – 20 h in cell culture (GERNER et al., 2002). 
The heat shock response is triggered by accumulation of unfolded and 
misfolded proteins (BENARROCH, 2011). In a physiological state, 
members of HSPC (HSP90) family bind to a transcription factor called 
heat shock factor-1 (HSF-1), keeping it inactive in the cytoplasm. In 
the presence of improperly folded or unfolded polypeptides, HSPs 
dissociate from HSF-1, enabling it to undergo trimerisation, followed 
by its translocation into the nucleus, where it binds to heat shock 
elements in HSP genes, activating the production of HSPA, DNAJ and 
HSPB proteins. The basic function of HSPs as chaperones is refolding 
misfolded proteins due to conformational changes and hydrolysis of 
adenosine triphosphate (ATP). However, if abnormal proteins cannot 
be repaired, HSPs target them for degradation by the ubiquitin-
proteasome pathway or by lysosome-mediated autophagy 
(BENARROCH, 2011). The chaperone role of HSPs is of high 
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importance especially in neuronal cells, since they cannot dilute the 
concentration of protein aggregates through mitosis (TURTURICI et 
al., 2011). 
HSPA family proteins are extremely highly conserved proteins 
(showing 68% homology between HSPA1 of E. coli and HSPA8 of 
humans (ZUIDERWEG et al., 2013)), therefore studying their 
properties in one organism poses a good approximation of their 
behaviour in the others. HSPA1 and its cognates are built in form of 
dimers, each of them containing three domains: 
 N-terminal nucleotide-binding domain (NBD) of ca. 45 kDa, 
serving the purpose of binding and hydrolysing ATP 
 C-terminal substrate-binding domain (SBD) of ca. 25 kDa, 
further subdivided into: 
o β-sandwich subdomain functionally serving as a 
binding scaffold that interacts with substrate proteins 
o α-helical, flexible subdomain, able to adopt an open 
or a closed conformation and acting as a lid, which 
has no direct contact with the substrate 
 short (around 10-15 kDa) linker domain, a highly conserved 
and hydrophobic structure (TURTURICI et al., 2011; 
MALYSHEV, 2013; ZUIDERWEG et al., 2013; MORGNER et 
al., 2015; FERNANDEZ-FERNANDEZ & VALPUESTA, 
2018). 
HSPA1 requires specific monovalent and divalent metal ions (K+ and 
Mg2+) to perform its weak ATPase activity. It adopts three 
conformations, one bound to adenosine diphosphate (ADP), one 
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bound to ATP and one in the absence of a nucleotide (TURTURICI et 
al., 2011; ZUIDERWEG et al., 2013). In the presence of ATP, the lid 
subdomain of the SBD remains open, allowing substrates to bind (or 
products to dissociate). Nucleotide hydrolysis closes the lid and 
enhances substrate affinity (TURTURICI et al., 2011; ZUIDERWEG et 
al., 2013). However, HSPA1 is not tightly locked in one of the two 
conformations in the cycle – substrates are also able to bind to the 
SBD in the ADP-bound conformation. Similarly, in the presence of 
ATP, the lid may not remain fully open, suggesting several 
conformations present on different time scales in the presence of both 
nucleotides (GENEST et al., 2019). The communication between the 
domains runs bidirectionally, since interactions between the SBD and 
its substrates can increase the rate of ATP hydrolysis (TURTURICI et 
al., 2011). 
In its role of the chaperone, HSPA1 requires: cochaperones, including 
members of DNAJ (HSP40) family, which deliver substrates to HSPA1 
and stimulate ATP hydrolysis; nucleotide exchange factors, which 
increase the rate of nucleotide exchange of the NBD; HSPA1-
interacting protein, which assists in retaining substrates (MALYSHEV, 
2013). During protein folding, HSPA proteins cooperate with members 
of HSPC (HSP90) family to coordinate folding and maturation of client 
substrates. In protein disaggregation processes HSP are assisted by 
heat shock proteins of 100 kDa molecular weight and HSPH 
molecules (DRAGOVIC et al., 2006; FERNANDEZ-FERNANDEZ & 
VALPUESTA, 2018). 
HSPA1 plays a crucial role in protein degradation. It facilitates 
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ubiquitination of its client proteins as well as their delivery to 
proteasome, but also assists in endosomal microautophagy and 
macroautophagy (FERNANDEZ-FERNANDEZ & VALPUESTA, 
2018). 
Protective function of several HSPs is expressed also in their role of 
regulators of apoptosis. HSPA1 acts as an inhibitor of apoptosis on 
three levels: premitochondrial, mitochondrial and postmitochondrial 
stage. At the first stage, HSPA1 inhibits stress-activated c-Jun N-
terminal kinase, critical for upregulation of pro-apoptotic genes 
(DHANASEKARAN & REDDY, 2008). At the mitochondrial level, it 
inhibits the translocation of C-cell lymphoma 2-associated protein X to 
the mitochondrial outer membrane, therefore protecting it from its 
permeabilisation and release of cytochrome c (BENARROCH, 2011; 
RICHTER-LANDSBERG, 2011). Postmitochondrially, HSPA1 binds to 
apoptotic protease activating factor 1, preventing apoptosome 
formation and caspase 9 activation. Finally, by binding to another 
mitochondria-associated protein, apoptosis-inducing factor, HSPA1 
inhibits caspase-dependent nuclear fragmentation (RICHTER-
LANDSBERG, 2011). 
HSPs are intracellular chaperones, they can, however, be expressed 
extracellularly, in the plasma membrane or in the extracellular space, 
where they have the capacity to activate the immune system (VEGA 
et al., 2008; BENARROCH, 2011). Initially they were believed to be 
released from necrotic cells. However, HSPs proved to be present in 
the extracellular matrix in the absence of cell death. Members of HSPA 
and HSPC families can be transported and released via exosomes or 
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in an endolysosomal-dependent pathway (VEGA et al., 2008). 
Extracellular HSPA1 is recognised by major histocompatibility 
complex class I molecules, triggering specific CD8+ T-cell responses 
(BENARROCH, 2011). It has been described as a DAMP, knowing to 
bind to human monocytes and activating pro-inflammatory cytokine 
cascades, such as induction of above-mentioned IL-1R/TLR signalling 
(ASEA et al., 2000; VABULAS et al., 2002a; TSAN & GAO, 2004; YU 
et al., 2010). The protein has shown immunomodulatory 
characteristics in interstitial spaces and tissue fluids (POCKLEY et al., 
1998; MAMBULA & CALDERWOOD, 2006). Whether HSPA1 
augments or suppresses inflammation seems to depend also on a 
type of activated receptor (FONG et al., 2015), leading to contradictory 
views on a function of a single protein. It has been also discussed that 
endotoxin contamination could be responsible for such particular 
outcomes regarding the role of secreted HSPA1 (GAO & TSAN, 
2003). 
HSPA1 seems to play a protective role in cells, prolonging their 
viability after exposure to several stress factors. Overexpression of 
inducible HSPA1 showed protective effects against sublethal heat 
stress in cultured hippocampal neurons (BEAUCAMP et al., 1998) and 
against hypoxia in chondrocyte cell culture (TSUCHIDA et al., 2014). 
Moreover, in the diseases of proteostasis (including Alzheimer, 
Parkinson and Huntington diseases), characterised by misfolding of 
normal cell proteins and their subsequent aggregation and 
accumulation in the form of inclusions, HSPs suppress 
neurodegeneration. Overexpression of different HSPs inhibits the 
aggregation of falsely folded proteins and protects against cell death 
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in models of Parkinson disease, Huntington disease and amyotrophic 
lateral sclerosis (BENARROCH, 2011). The induction of the 
overexpression of HSPA1 and associated chaperones, e.g. by using 
a compound able to upregulate HSP gene expression like celastrol, 
has neuroprotective effects in vivo in animal models of Alzheimer 
disease and Huntington disease. The role of HSPA1 in epilepsy 
models remains however uncertain. In the kainic acid rat model of SE, 
HSPA1 expression was upregulated in the early post-insult phase 
brain-wide in regions related to epileptogenicity (SANZ et al., 1997). 
Despite the expression of HSPA1, no neuroprotection was observed, 
showing severe neuronal loss and gliosis in the hippocampus as well 
as an increase of dying cells (YANG et al., 2008; TURTURICI et al., 
2011). In this case, HSPA1 may only serve as an indicator of neuronal 
stress in the acute phase of epileptogenesis. In the kindling model, 
upregulation of HSPA1A gene proved to have a pro-epileptogenic 
effect, promoting ictogenesis in naïve animals (VON RUDEN et al., 
2018). Conversely, a similar study conducted on HSPA1A-deficient 
mice supports a protective role of HSPA1 with an effect on microglia 
activation in hippocampus and on spread of seizure activity (VON 
RUDEN et al., 2019). 
A putative neuroprotective role of extracellular HSPA1 in epilepsy has 
been suggested in several studies. EKIMOVA et al. (2010) 
demonstrated for the first time anticonvulsive properties of exogenous 
HSPA1. In this study, HSPA1 and HSPA8 (HSC70) injection exerted 
a seizure attenuating effect in a chemically induced SE model. Both 
proteins proved to be able to modulate GABAergic transmission and 
to penetrate into brain areas involved in generation and propagation 
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of generalised seizures (like cortex, hippocampus, and thalamus). 
Extracellular HSPA1 has also shown neuroprotective effects in 
different brain injury models (BENARROCH, 2011; KIM & YENARI, 
2013; KIM et al., 2018), as well as in lethal oxidant lung injury, where 
activation of TLR4 signalling expressed potent cytoprotective 
properties (ZHANG et al., 2013a). This double-faced functionality of 
HSPA1 inside and outside of cells suggests possible scenarios in 
therapy development targeting HSPA1 expression. 
4.3. Heat shock proteins in the endoplasmic reticulum 
In eukaryotic cells, most proteins destined for secretion or membrane 
expression are synthesised in the endoplasmic reticulum (ER). Its 
physical segregation from the cytosol leads to a distinct folding milieu 
with proper protein machinery engaged in processes of folding, 
assembly, modification, quality control and recycling (BRAAKMAN & 
BULLEID, 2011). Correct protein folding and maturation is the role of 
compartment-specific chaperones. An imbalance between the load of 
proteins to be folded and the folding capacity of local chaperones 
leads to aggregation of misfolded proteins and a condition known as 
ER stress (PREISSLER & RON, 2018). Several heat shock proteins 
are involved in the ER stress response, among which two of them, 
HSPA5 and HSPH4, are the topic of this monography. 
HSPA5 
In HSPA family, HSPA1 is present ubiquitously in the tissue. In the 
cell, it localises mostly in the cytosol, similarly to the constitutive form 
of the protein, HSPA8, which can be found in the cytosol as well as in 
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the nucleus. HSPA5 is a homologue form of HSPA8 present 
predominantly in the endoplasmic reticulum, it can be however found 
also on the cell surface, in the extracellular matrix, in the cytosol and 
in the mitochondria, where it plays various roles (VOS et al., 2008; NI 
et al., 2011). 
Endoplasmic HSPA5 is essential for the normal functioning of the ER 
and is widely used as a marker of ER stress (NI et al., 2011). It is 
involved in translocating the newly synthesised polypeptides across 
the ER membrane, facilitating the folding and assembly of proteins, 
targeting misfolded proteins for ER-associated degradation, regulating 
calcium homeostasis, and serving as an ER stress sensor (WANG et 
al., 2009). It is also one of the main factors of the unfolded protein 
response (UPR), a set of dynamic adjustments within the ER aimed to 
protect protein homeostasis inside the compartment as a result of 
stress. The UPR depends on activation of transmembrane signal 
transducers: inositol-requiring enzyme 1 (IRE1), protein kinase R-like 
ER kinase (PERK) and activating transcription factor 6 (ATF6). Their 
activation evokes two main downstream effects: it limits the influx of 
proteins into the ER to lower the folding load and upregulates the 
expression of proteins involved in ER protein quality control to 
increase the folding capacity in the ER (PREISSLER & RON, 2018). 
In the physiological conditions, HSPA5 is bound to the signal 
transducers, involving its typical substrate-like interactions 
(PREISSLER & RON, 2018) Following the ER stress, HSPA5 is 
released from the signal transducers, which leads to the activation of 
the UPR signalling pathways (WANG et al., 2009). The response 
involves both rapid posttranslational regulation of active chaperones 
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in the ER and the slower induction of ER protein quality control genes. 
In the end, it promotes degradation of cytotoxic misfolded proteins and 
cell survival (WANG et al., 2009). However, if the stress is too long or 
too severe to cope with, the ER stress-induced apoptosis pathways 
can be activated (WANG et al., 2009). 
HSPA5 has a relatively long half-life in cell culture (≥24 h) and in 
tissues (≥3 days) and is present at high basal concentrations in the 
ER. The prolonged ER stress conditions can increase the HSPA5 
expression several fold (PREISSLER & RON, 2018). In the ER, it can 
be present in an active or an inactive state, where the other one can 
be achieved either by posttranslational modification or by protein 
storage. The regulation involving posttranslational changes is based 
most prominently on binding of adenosine monophosphate (AMP) via 
a phosphodiester bond to HSPA5 (AMPylation), which locks the 
protein in a low-affinity state for substrates, therefore causing its 
functional inactivation. This process is especially prominent during the 
recovery period after the prolonged ER stress, since the HSPA5 half-
life is relatively long. The chaperone can also be deposited into a 
dynamic inactive pool of proteins by its oligomerisation, which utilises 
the competitive binding of other HSPA5 proteins instead of substrates, 
consequently lowering non-productive interactions with proteins in 
conditions of low folding need. AMPylated HSPA5 is excluded from 
oligomers, since its substrate affinity is low (PREISSLER & RON, 
2018). Oligomerisation is a rapid process, facilitating HSPA5 
availability on short timescale (seconds to minutes), while AMPylation 
operates in longer (minutes to hours) timeframes (PREISSLER & 
RON, 2018). In total, the concentration of overall HSPA5 molecules in 
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the endoplasmic reticulum vastly exceeds the concentration of 
molecules able to engage substrates. 
In other cell compartments, as well as outside the cell, HSPA5 has 
several additional functions. ER stress leads not only to increase of 
HSPA5 levels in the ER, but also promotes the relocalisation of the 
protein to the cell surface, where it acts as a receptor for pro-survival 
growth signalling, but also for viral internalisation (as in case of Borna 
disease virus or Japanese encephalitis virus) (NI et al., 2011; NAIN et 
al., 2017). HSPA5 is expressed on the cell surface of proliferating 
cells, making it a suitable target for novel anti-cancer therapy methods 
(NI et al., 2011). HSPA5 is present also in the cytoplasm, where it 
functions as a regulator of the UPR signalling – the cytosolic form is 
however a product of alternative splicing of HSPA5 gene. 
HSPA5 is often secreted into the extracellular space, both under the 
pathological and in physiological conditions. High HSPA5 levels were 
observed in tumour matrix (KERN et al., 2009) as well as in sera of 
patients with gastric cancer (TSUNEMI et al., 2010). Studies indicate 
an increased secretion of HSPA5 into the bronchoalveolar lavage fluid 
in chronic cigarette smokers (AKSOY et al., 2017). In addition, HSPA5 
has been found in the oviductal fluid from healthy women in the 
periovulatory period, having the ability to regulate the binding of sperm 
to the zona pellucida during fertilisation (MARIN-BRIGGILER et al., 
2010). These findings strongly suggest the role of the protein in 
modulation of many biologically crucial processes in both normal and 
pathologically changed tissue. 
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HSPH4 
HSPH (HSP110) family is a part of HSP superfamily and is closely 
associated with HSPA proteins in its molecular form and function in 
the cell (LIN et al., 2001; DRAGOVIC et al., 2006). Substrates enter 
the HSPA complex in the configuration bound to ATP, when the 
substrate change rate is high and the affinity is low. ATP hydrolysis 
performed by cofactors, i.e. of DNAJ family, stabilises the affinity of 
HSPA protein to its substrate. As a result, nucleotide exchange factors 
are activated to transpose ADP with ATP, which is followed by a 
substrate release. One of those ATP exchange factors are, in 
mammalian cells, proteins belonging to HSPH family (DRAGOVIC et 
al., 2006; VOS et al., 2008). HSPH proteins are known to prevent 
aggregation by binding protein substrates and holding unfolded 
proteins in a folding-competent state, so they can act as both substrate 
loaders (similarly to DNAJ family members) and nucleotide exchange 
factors in the HSPA chaperoning complex (DRAGOVIC et al., 2006; 
VOS et al., 2008). The results of titration revealed that HSPH proteins 
are the most effective for folding at ratios equimolar to HSPA 
(DRAGOVIC et al., 2006). 
Four known HSPH proteins are highly homologous to HSPA family 
members. The linker domain is however longer, with insertions of 
varying lengths, as well as the C-terminus is less conserved in the 
HSPH family (DRAGOVIC et al., 2006; VOS et al., 2008). Among four 
HSPH family members, HSPH4 (also known as 170 kDa glucose-
regulated protein, Grp170, 150 kDa oxygen-regulated protein, 
ORP150, and Hypoxia Upregulated 1, HYOU1) is a chaperone located 
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in the endoplasmic reticulum. The plethora of its names reflects the 
conditions in which the protein gets induced – which include hypoxia, 
nutrient (especially glucose) deprivation as well as reducing agents, 
low pH and calcium depletion (WANG et al., 2014). In the ER, it fills a 
role of a nucleotide exchange factor for HSPA5, where it enhances 
substrate release in an ATP-dependent manner (DRAGOVIC et al., 
2006). 
Mutations in nucleotide exchange factor genes may cause several 
disorders. The mutation in SIL1 gene, coding a protein associated with 
HSPA5, inactivates its nucleotide exchange function and potentially 
causes Marinesco-Sjörgen syndrome, an autosomal recessive 
neurodegenerative disease in humans as well as ataxia phenotype in 
woozy mice, associated with selective Purkinje cell degeneration 
(DRAGOVIC et al., 2006). This suggests that correct function of 
nucleotide exchange factors is crucial for cellular homeostasis and 
their levels may vary depending on the cell type. The role played by 
ER stress over status epilepticus induced cell death is still debated. 
Some authors report that ER stress causes neuronal death (SOKKA 
et al., 2007; CHEN et al., 2013), while others sustain its role in pro-
survival mechanisms (KITAO et al., 2001). 
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III. SCOPE OF THE DISSERTATION 
So far, several studies described expression of HSPA1 in chemically 
induced SE rodent models, connecting excessive neuronal activity 
with induction of the protein (VASS et al., 1989; LIVELY & BROWN, 
2011; RICHTER-LANDSBERG, 2011). No such investigations exist at 
the moment for ER heat shock proteins, HSPA5 and HSPH4. The aim 
of this study is to describe the expression profile of selected HSPs in 
the model of electrically induced SE, which already demonstrated 
alterations in expression of several DAMPs in the course of 
epileptogenesis (WALKER et al., 2016; KECK et al., 2018). By means 
of comprehensive proteome analysis, five heat shock proteins were 
found to be upregulated in the brain undergoing epileptogenesis, with 
a pronounced upregulation of HSPA1 in the hippocampus and in the 
parahippocampal cortex in the early post-insult phase and in the 
latency phase. HSPA5 and HSPH4 exhibited a slight upregulation in 
the acute post-SE phase and in the latency phase. The goal of this 
study was to quantitatively measure and qualitatively assess 
expression of proteins interest in different cell populations in 
hippocampal, parahippocampal and accessory regions relevant for 
epileptogenesis. 
 
56 
IV. MATERIALS AND METHODS 
1. Animals 
1.1. Rat electrical status epilepticus model 
For purposes of this project, brain tissue samples were collected from 
animals used in the proteomics study by Andreas Walker as a part of 
his dissertation at the Institute of Pharmacology, Toxicology and 
Pharmacy of the Faculty of Veterinary Medicine of Ludwig-
Maximilians-University in Munich (WALKER et al., 2016). Therefore, 
the description of all in vivo procedures relates to that study. Briefly, 
female Sprague Dawley rats (n = 47) were housed under controlled 
standard environment conditions. Females proved to show a lower 
mortality rate than males in the characterisation of the model 
(BRANDT et al., 2003), this being the reason to use only specimens 
of this sex.  
Experimental procedures were carried out in accordance with the 
German Animal Welfare Act, the European Communities Council 
Directive of 22 September 2010 (2010/63/EU), approved by the 
Committees of the Government of Upper Bavaria (reference number: 
AZ 55.2-1-54-2532-94-11, AZ 55.2-1-54-2532-011-2015) and in 
compliance with the ARRIVE (Animal Research: Reporting of In Vivo 
Experiments) guidelines. During the experiment, every attempt was 
made to minimise pain or discomfort as well as to lower the number of 
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animals used. 
For the purposes of this study, animals were assigned either to a SE 
or to a control group. Sampling of brain tissue was later performed at 
three different time points during epileptogenesis (Fig. 2): 
 two days post-SE (early post-insult phase),  
 ten days post-SE (latency phase) 
 eight weeks post-SE (chronic phase with SRSs). 
 
Figure 2. For the purpose of immunohistochemical staining, brain tissue 
samples were collected from electrically-stimulated rats as well as from 
control animals at three time points, corresponding to the early post-insult 
phase (2 days following SE), the latency phase (10 days following SE) and 
the chronic phase with spontaneous recurrent seizures (8 weeks following 
SE).  
All of the animals underwent a stereotaxic surgery to implant an 
electrode into the right basolateral amygdala (BLA) performed under 
general anesthesia. The electrode served for both electrical 
stimulation and EEG recording. Following the electrode implantation, 
animals were left to recover for the period of six weeks. Afterwards, 
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self-sustained status epilepticus was evoked using the protocol 
established already at the institute (ONGERTH et al., 2014). A self-
sustained SE was confirmed by EEG recording and it was interrupted 
by intraperitoneal administration of diazepam 4 hours after the start of 
the stimulation. Animals’ behavioural seizure activity was scored for 
the entire duration of SE using the Racine scale (RACINE et al., 1972) 
in which five stages of seizure severity can be observed: 
 stage 1: animal immobility and facial automatisms (eye 
closure, facial clonus), 
 stage 2: head nodding and more severe facial and 
mouth clonus (mastication), 
 stage 3: unilateral forelimb clonus, 
 stage 4: rearing and bilateral forelimb clonus, 
 stage 5: rearing and falling accompanied by generalised 
tonic–clonic seizures. 
Furthermore, animals were grouped according to the types of status 
epilepticus described above (partial non-convulsive, partial non-
convulsive with occasional generalisation or generalised convulsive 
SE). For subsequent experiments, only animals exhibiting generalised 
convulsive seizures were included, constituting 85% of the whole 
population (WALKER et al., 2016). Animals assigned to the group with 
sampling eight weeks after SE (corresponding to development of 
spontaneous recurrent seizures) underwent continuous video- and 
EEG-monitoring. 
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1.2. Canine clinical model 
Canine brain tissue was collected from 48 dogs aged from two months 
to 15 years, which either had been undergoing treatment at the Small 
Animal Clinic of the University of Veterinary Medicine in Hanover, 
Germany, or had served previously as experimental animals in 
parasitology study at the Institute of Parasitology of the same 
university. Dogs were distributed into different groups, depending on 
whether seizure frequency or aetiology of the disease was taken into 
consideration: 
1. Patient control group (CTRpat) comprising owner kept dogs 
without clinically nor pathologically stated diseases of the 
central nervous system (n = 18, age range 2-180 months; 
mean 70.67  12.58) 
2. Experimental control group (CTRexp) consisting of 
experimental dogs without neurological diseases, but 
infested with Toxocara canis and Uncinaria stenocephala or 
Angiostrongylus vasorum (n = 10, age range 4-12 months; 
mean 7.33  3.94) 
3. Epileptic animals: 
a. Grouping according to the aetiology as defined by 
international veterinary task force (BERENDT et al., 
2015): 
i. Structural epilepsy caused by identified 
cerebral pathology (n = 12, age range 30-
140 months; mean 81.17  12.29) 
ii. Idiopathic epilepsy group, subtype unknown 
cause and no identification of structural 
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epilepsy (n = 8, age range 2.5 - 157 months; 
mean 51.94  18.82) 
b. Grouping according to the occurrence of seizures 
(BERENDT et al., 2015): 
i. Seizure clusters, defined clinically as two or 
more incidents within a 24 h period (n = 9, 
age range 80 - 140 months; mean 68  
15.63) 
ii. Status epilepticus, defined clinically as 
epileptic seizures of duration ≥ 5 min ( n = 4, 
age range 36 - 120 months; mean 67.75  
20.15) 
 
According to the information gathered in the anamnesis, all epileptic 
canine patients included in the study exhibited convulsive seizures, 
either focal or generalized. No report about atonic, myoclonic or 
absence type of seizures was present. The first seizure event before 
the last clinical presentation, followed by death or euthanasia, 
occurred within a time interval from one day up to eleven years. Onset 
of seizures before death and euthanasia varied between one hour and 
one week. The seizure frequency ranged from one episode a month 
to four seizures a day. 
The neuropathological examination of dogs belonging to the group 
with structural epilepsy revealed four cases of meningoencephalitis, 
three of brain tumour (meningioma and glioblastoma), two of 
hydrocephalus, two of vacuolisation in the white matter, one of 
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encephalomalacia (possibly as a result of cerebral infarct) and one of 
toxoplasmosis. Animals from patient control group demonstrated 
cardiovascular pathological changes (eight animals), not 
neurologically related neoplasms (three patients) and other disorders: 
splenic and gastric torsion, pneumonia, foreign bodies in stomach. 
All animal experiments using canines were conducted in accordance 
with the German Animal Welfare Law and were approved by the local 
authorities (Niedersächsisches Landesamt für Verbraucherschutz und 
Lebensmittelsicherheit (LAVES), Oldenburg, Germany, permission 
numbers: 33.9-42502-05-12A241, 33.19-42502-05-16A044). The 
owners of dogs included in this study signed an informed consent 
form. 
  
62 
2. Tissue processing 
Rat brain samples were collected after the perfusion process. Animals’ 
skulls were opened using surgical tools and brains were softly 
extracted with a spatula. Afterwards, they were placed in 4% 
paraformaldehyde solution (pH 7.4) for 24 hours at 4°C. 
Consecutively, samples were transferred to a 30% sucrose solution in 
0,01 M phosphate buffered saline (PBS) for cryopreservation and left 
until tissue sank (24-72 hours, depending on the brain size). After 
reaching this stage, tissue was embedded in optimal cutting 
temperature compound and cut on a cryostat in 18 series, each 
consisting of ten to twelve 40 µm thick slices in coronal plane. For the 
analysis, only slices containing hippocampus, parahipocampal cortex 
and accessory regions (thalamus, amygdala, parietal cortex) were 
considered relevant, so only samples from bregma +1.56 to -9.00 
(PAXINOS & WATSON, 2005) were saved. Slices were later 
embedded in a cryoprotective solution (30% glycerol, 30% ethylene 
glycol, 0,1M PBS) and stored at -80°C. 
In canine patients, during post-mortem examinations, brains were 
inspected macroscopically, removed and fixed in 10% formalin for 
several days, then cut by in blocks by means of matrices, embedded 
in paraffin wax and cut transversally to 2 µm thick sections. Slices 
containing the hippocampus in a range from #1360 to #1660 of the 
canine brain atlas (WALLY WELKER, 2015) were mounted on 
positively charged microscope slides and stored at room temperature 
at the Department of Pathology of the University of Veterinary 
Medicine in Hanover, Germany. 
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Brain tissue from the archive of the Department of Pathology of the 
University of Veterinary Medicine in Hanover has been used in 
accordance to the ethical rules and in compliance with the 
recommendations of the University of Veterinary Medicine in Hanover, 
Germany. 
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3. Immunostaining 
To perform both quantitative and qualitative analysis, proteins of 
interest (HSPA1, HSPA5, HSPH4) were stained by means of 
immunohistochemistry (IHC). 
HSPA1 – single immunostaining 
To perform HSPA1 quantification, rat brain samples were stained by 
means of 3,3’-diaminobenzidine colour reaction. Free-floating frozen 
sections were first washed thrice at room temperature in Tris-buffered 
saline (TBS) for 10 minutes each washing step. Then, to reverse 
chemical antigen modifications caused by formaldehyde fixation of the 
tissue, heat-induced epitope retrieval (HIER) process was performed 
at 80°C for 30 minutes using sodium citrate buffer (pH 6.0). 
Endogenous peroxidase activity was inhibited by incubating brain 
slices in 1% H2O2 in TBS during 30 minutes. Afterwards, a blocking 
step in 5% normal goat serum (NGS) diluted in TBS was performed to 
prevent any non-specific antibody binding. Consequently, overnight 
(16h) incubation of brain sections with anti-Hsp70/Hsp72 (anti-
HSPA1) antibody was performed at 1:750 dilution at 4°C. All 
antibodies described in this publication used for staining of rat tissue 
were diluted in an antibody carrier (1% bovine serum albumin, 1% 
NGS, 0.3% Triton in TBS). Following the primary antibody incubation, 
the slices were washed three times in TBS and then incubated with 
biotinylated goat anti-mouse secondary antibody at dilution 1:1000 for 
2 hours at room temperature. After three consecutive washes in TBS, 
incubation with horse radish peroxidase-coupled streptavidin was 
performed at 1:1400 dilution for one hour at room temperature, 
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followed by three more washing steps in TBS. Afterwards, a colour 
reaction was implemented, using 3,3'-diaminobenzidine tetra 
hydrochloride (DAB) converted by horse radish peroxidase into a 
brown product. DAB is water-soluble in its unoxidised form, it creates 
however precipitates after oxidisation, making localisation of proteins 
of interest visible. For this reaction, 0.05% DAB was used, with 
addition of 0.01% H2O2 and 0.01% nickel ammonium sulfate. Nickel is 
a known enhancer of DAB signal, yielding in intense, dark blue 
staining. Subsequently, stained sections were mounted on positively 
charged microscope glasses and cover-slipped with Entellan. 
HSPA1 – multiple immunostaining 
To determine the expression profile in main cell types involved in 
epileptogenesis and/or inflammation processes in the central nervous 
system, several double immunolabelling procedures of HSPA1 and 
cell markers were performed. Chosen biomarkers included: NeuN 
(Fox-3, Rbfox3, or Hexaribonucleotide Binding Protein-3), neuronal 
nuclear antigen commonly used to label neurons; GFAP (glial fibrillary 
acidic protein), to mark astrocytes and Iba1 (ionized calcium-binding 
adapter molecule 1), also known as AIF-1 (allograft inflammatory 
factor 1), expressed in macrophages and microglia. 
For HSPA1 double immunostaining with markers for various cell 
populations of the brain, three different protocols were used. For the 
immunofluorescent labelling with NeuN, free-floating sections were 
firstly washed three times in TBS with 0.05% Tween (TBST) and 
underwent heat-induced epitope retrieval as described above. Later, 
slices were incubated with blocking solution (5% NGS and 2% bovine 
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serum albumin in TBS) at room temperature. Both primary antibodies 
were acquired from the same host (mouse), therefore they were 
applied to the sections sequentially to exclude the possibility of cross-
binding of secondary antibodies, reactive against the same host. 
Briefly, samples were incubated with anti-Hsp70/Hsp72 antibody 
(clone description above) at 1:1500 dilution overnight (16 h) in a cold 
room (4°C). The following day, after three further washes in TBST, 
goat anti-mouse biotinylated secondary antibody was applied at 
1:1000 dilution for 1 h at room temperature. Afterwards, sections were 
washed thrice in TBST and incubated with streptavidin coupled with a 
Cyanine Dye 3 (Cy3), to amplify the signal. Concentrations were 
selected to fulfil as many binding sites on the primary antibody as 
possible and lower the risk of cross-binding of the second secondary 
antibody. After finishing the construct for the first marker, slices were 
again washed in TBST and incubated overnight in a cold room (16 h, 
4°C) with anti-NeuN antibody at dilution of 1:500. The next day, after 
further washing in TBST, slices were incubated with goat anti-mouse 
secondary antibody coupled with an Alexa Fluor 488 dye at 1:750 
dilution for 1 h. Afterwards, sections were rinsed thrice in PBS and 
counterstaining of cell nuclei with Hoechst 33342 dye at 0.5 µg/mL 
concentration was performed for 5 minutes. Finally, stained slices 
were mounted on microscope glass and cover-slipped with 
immunofluorescence anti-fading medium. 
For double immunolabelling of HSPA1 with GFAP, sections were 
processed with HIER and incubated in a blocking solution as 
described above. Since both primary antibodies were obtained from 
different host species (anti-HSPA1 – mouse, anti-GFAP – rabbit), 
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parallel staining method was chosen, meaning free floating slices 
were incubated with both antibodies at the same time (overnight – 16 
h, at 4°C, anti-HSPA1 dilution: 1:1500; anti-GFAP dilution: 1:3000). 
The following day, three washes in TBST were performed. Afterwards, 
slices were incubated with goat anti-mouse secondary antibody 
coupled with a Cyanine Dye 2 (Cy2; 1:1000 dilution) and goat anti-
rabbit secondary antibody linked to an Alexa Fluor 594 dye (1:1000 
dilution) for 1 h at room temperature. Sections were then washed 
thrice in PBS, counterstained with Hoechst 33342 (0.5 µg/mL), 
mounted on a microscope glass and cover-slipped using 
immunofluorescence anti-fading mounting medium, analogically to the 
HSPA1/NeuN staining. 
To show interactions between HSPA1 and TLR4 as well as with 
microglia, triple immunostaining was performed. For that purpose, free 
floating slices were processed with HIER as described above. 
Possible unspecific binding target sites were blocked using blocking 
solution containing 2% of bovine serum albumin and additional 0.1% 
cold fish skin gelatine to improve penetration of antibodies into the 
tissue (ZUKOR et al., 2010). Two out of three antibodies used were 
acquired from the same host species (anti-HSPA1 – mouse, anti-
TLR4 – mouse), therefore they were applied to the sections in a 
sequential manner. Firstly, samples were incubated with anti-HSPA1 
antibody at 1:1500 dilution overnight in a cold room (16 h, 4°C). 
Afterwards, following three washing steps in PBS with 0.05% Tween 
(PBST), a biotinylated goat anti-mouse secondary antibody was 
added at dilution of 1:1000 and one-hour long incubation at room 
temperature was executed. Sections were again rinsed in PBST and 
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incubated with streptavidin coupled with a Cy3 dye at 1:1500 dilution 
for 1 h at room temperature. After three consecutive washes in PBS, 
sections were incubated with anti-TLR4 antibody at 1:250 dilution and 
anti-Iba1 antibody at 1:10000 dilution overnight in a cold room (16 h, 
4°C). Since both of the primary antibodies were obtained from different 
species (anti-Iba1 – rabbit), it was possible to add them in parallel 
without risking cross-binding. The day after, slices were washed in 
PBST three times and incubated with secondary antibodies: goat-anti 
mouse coupled with an Alexa Fluor 488 dye (1:500) and goat anti-
rabbit linked to an Alexa Fluor 647 fluorochrome (1:500). Incubation 
took 1 h at room temperature and was followed by additional washing 
steps in PBS, counterstaining with Hoechst 33342 (0.5 µg/mL), 
mounting on microscope glasses and cover-slipping with 
immunofluorescence anti-fading mounting medium. 
HSPA5 and HSPH4 – single staining in rats 
For immunohistochemical labelling of HSPA5 and HSPH4 in rats, 
frozen free floating sections were processed with HIER as described 
above. Activity of endogenous peroxidase was inhibited by 20 min 
incubation in 3% H2O2 diluted in TBS. Afterwards, possible non-
specific binding sites were blocked by a blocking solution (5% NGS, 
2% bovine serum albumin) applied for 60 min. Sections were then 
incubated with either an anti-ORP150/HSP12A (anti-HSPH4; 1:750 
dilution) or an anti-GRP78 BiP antibody (anti-HSPA5; 1:5000) 
overnight (16h) at 4°C. The day after, three washing steps in TBST 
were performed, following incubation with a biotinylated goat anti-
rabbit secondary antibody (dilution: 1:1000 for anti-HSPH4; 1:1500 for 
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anti-HSPA5) during 1h at room temperature. Slices were then rinsed 
thrice in TBST and incubated for 60 min at room temperature using 
VECTASTAIN ABC-Peroxidase Kit (1:100). ABC is an abbreviation for 
avidin-biotin complex, implementation of which is one of methods of 
amplification of the target antigen signal in immunohistochemistry 
(Fig. 3).  
 
Figure 3. Illustration of avidin-biotin complex formation. Biotin-containing 
enzyme molecules rapidly and firmly bind to avidin, forming a complex net-
like structure connected to the secondary antibody. The enzyme is later on 
involved in colour reaction with DAB. Modified from Dako Educational IHC 
Guidebook (CLIVE R. TAYLOR, 2006). 
  
70 
By allowing binding of biotin-containing enzyme molecules to avidin, a 
tetrameric glycoprotein, a complex net-like structure is formed, where 
avidin molecules are linked together by the biotinylated enzyme (in 
this case, peroxidase). A colour reaction was performed using 3,3’-
diaminobenzidine tablets according to the instructions found in the 
datasheet. Slices stained for HSPH4 were additionally counterstained 
with a Hemalum solution acidic according to Mayer to ensure a better 
cell and brain region recognition under the microscope. Afterwards, 
sections were mounted on microscope glasses and cover-slipped 
using Entellan, as described in the case of HSPA1. 
HSPA5 and HSPH4 – multiple staining 
Analogically to HSPA1, to describe the expression profile of HSPA5 
and HSPH4, double immunofluorescent labelling for neurons, 
astrocytes and microglia was performed. Six animals, three from 
control and three from SE groups, were randomly selected from the 
entire pool of animals for each time point (http://randomizer.org). 
Sections were initially rinsed thrice in PBST, followed by HIER as 
described above. Afterwards, a 1 h blocking step was performed at 
room temperature using PBS added with 2% BSA and 0.01% cold 
water fish skin gelatine in order to prevent unspecific bindings. Primary 
antibodies for the proteins of interest (anti-HSPA5, dilution 1:2500; 
anti-HSPH4, dilution 1:150) were incubated overnight in a cold room 
(4°C, 16 h) in combination with either antibodies aimed against NeuN 
(1:500), GFAP (1:1000) or Iba1 (1:1000). Following three PBST 
washes, sections were incubated with secondary antibodies. Alexa 
Fluor 594-conjugated goat anti-rabbit antibody (1:1000, 1 h, 24°C) 
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was used to label HSPA5, while biotinylated goat anti-rabbit (1:1000, 
1 h,  24°C) together with Cy3-conjugated streptavidin (1:2000, 1 h, 
24°C) was used to target HSPH4. Alexa Fluor 488-conjugated goat 
anti-mouse antibody was used to label both NeuN and GFAP (1:1000, 
1 h, 24°C) while for Iba1 labelling Cy2-conjugated donkey anti-goat 
antibody (1:1000, 1.5 h, 24°C) was chosen. Since in all of the cases 
primary antibodies were gained from different host species, they could 
be incubated in parallel without risking cross-linking of secondary 
antibodies. Finally, after three following washing steps in PBS, slices 
were counterstained using Hoechst 33342 (0.5 mg/mL), mounted on 
microscope glasses and cover-slipped with Immunoselect Antifading 
Mounting Medium. 
HSPA5 and HSPH4 – single staining in dogs 
In canine tissue, HSPA5 and HSPH4 stainings were performed in 
paraffin-embedded whole-mount sections, therefore all incubation 
processes took place in humidity chambers. Slices were initially 
deparaffinised and rehydrated by means of ethanol and xylene 
gradients. Afterwards, sections were processed with HIER as 
described for rat tissue. Then, activity of endogenous peroxidase was 
inhibited with 3% H2O2 and non-specific binding sites were blocked 
using solution containing 0.25% casein in TBS. Subsequent 
incubation with primary antibodies (anti-HSPA5, dilution 1:50; anti-
HSPH4, dilution 1:50), suspended in antibody carrier (0.25% casein in 
TBST) was performed overnight in a cold room (16h, 4°C). The day 
after, following the initial triple wash performed in glass cuvettes, 
incubation with a biotinylated goat anti-rabbit secondary antibody 
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(dilution 1:500) was performed for 1 h at room temperature. 
Afterwards, sections were rinsed thrice in TBST and incubated in 
VECTASTAIN ABC-Peroxidase Kit (dilution 1:100) for 1 h at room 
temperature. A colour reaction was developed using 3,3’-
diaminobenzidine tablets dissolved according to manufacturer’s 
instructions and counterstaining with Hemalum solution acidic 
according to Mayer was performed. Slices were then held for 15 
minutes under running tap water to remove undesirable over-
colouration and non-specific background staining caused by Hemalum 
solution. Finally, microscope glasses with brain sections were air dried 
in a fume hood overnight and cover-slipped the following day with 
Entellan. 
In both, rat and canine samples, negative controls were processed in 
the same manner as experimental sections, with omission of primary 
antibody incubation. 
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4. Image analysis 
4.1. Stereological cell counting 
To determine an approximate number of positive cells in rat brains, 
stereological cell counting using the optical fractionator method was 
implemented. The method uses thick (in this case, 40 µm) sections to 
estimate a total population of cells in an organ through cell numbers 
collected by systematic random sampling (SRS). To achieve that, an 
unbiased grid of virtual counting spaces is created by a software. The 
spaces are distanced regularly in X, Y and Z directions and cover the 
whole region of interest. The software is able of estimation of the total 
number of objects based on the number of objects marked by an 
operator. It is also able to calculate the volume of the region of interest, 
using the Cavalieri principle (GUNDERSEN, 1986; GUNDERSEN & 
JENSEN, 1987; WEST et al., 1991; GARCIA-FINANA et al., 2003). 
In this study, stereological cell counting was performed in rat brain 
sections distanced from each other by 720 µm. Three proteins of 
interest (HSPA1, HSPA5 and HSPH4) were analysed in following 
brain regions: 
 Hippocampus: 
o Hilus of dentate gyrus (corresponding to the layer of 
polymorphic cells of dentate gyrus), bregma from -
2.16 to -6.36 mm, Hil 
o Cornu Ammonis region 1 (pyramidal cell layer), 
bregma from -2.28 to -6.60 mm, CA1 
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o Cornu Ammonis region 3 (pyramidal cell layer), 
bregma from -1.72 to -6.12 mm, CA3 
 Parahippocampal cortex: 
o Perirhinal cortex, bregma from -3.00 to -9.00 mm, 
PRh 
o Entorhinal cortex, lateral and medial, bregma from -
3.12 to -9.00 mm, Ent 
o Piriform cortex, bregma from 1.56 to -4.92 mm, 
divided into: 
 Piriform cortex layer I, Pir1 
 Piriform cortex layer II, Pir2 
 Piriform cortex layer III, Pir3, 
considering their different susceptibility to electrical 
stimulation (VAUGHAN & JACKSON, 2014; VISMER et al., 2015). 
Additionally, in HSPA1 staining, several associated brain regions were 
analysed: 
 Thalamus (encompassing all thalamic subregions), bregma 
from -3.12 to -7.08 mm, Thal 
 Parietal association cortex (posterolateral and –medial 
parts), bregma from -3.00 to -6.12 mm, Par 
 Amygdala, bregma from -1.58 to -4.44 mm, Amy 
From each group (status epilepticus and control animals; 2 days, 10 
days and 8 weeks after electrical stimulation), six randomly selected 
animals were fully analysed. Cell counting was performed in a blinded 
manner, with all the samples randomised (http://randomizer.org). The 
exact number of quantified sections varied in the range between 13 
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and 27 slices. 
For stereological cell counting, an optical bright-field microscope 
equipped with a motorised stage and a colour CCD camera was used. 
Quantification was performed by means of Stereo Investigator 
software using the optical fractionator to assess the cell population 
and the Cavalieri’s principle to calculate volumes of given brain 
regions. The region area was restricted at low magnification (5x/0.12 
NA; Fig. 4), while cells were marked at high magnification (40x/0.65 
NA). 
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Figure 4. An exemplary image of region outlines performed at low (5x) 
magnification in Stereo Investigator software. Different colours of the contours 
indicate different regions of interest: purple - hilus of the dentate gyrus, green 
- Cornu Ammonis 3, blue - Cornu Ammonis 1. 
The size of the SRS grid as well as of counting frames were set 
experimentally, for each region separately, before the actual analysis. 
Cells were marked for counting according to instructions in software 
manual (BIOSCIENCE, 2019a). Briefly, all cells being in focus and 
lying within the optical fractionator counting frame or lying outside and 
being in contact with its green lines, but not crossing red lines, were 
counted (Fig. 5) 
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Estimated positive cells population and measured volume were 
afterwards used to calculate cell density in respective brain regions: 
𝐶𝑒𝑙𝑙 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 =
(𝐻𝑆𝑃𝐴1 𝑜𝑟 𝐻𝑆𝑃𝐴5 𝑜𝑟 𝐻𝑆𝑃𝐻4) 𝑝𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑐𝑒𝑙𝑙𝑠
𝐶𝑎𝑙𝑐𝑢𝑙𝑎𝑡𝑒𝑑 𝑣𝑜𝑙𝑢𝑚𝑒
 
 
 
Figure 5. An exemplary image of the counting frame used by the optical 
fractionator. Positively stained cells were quantified at high (40x) 
magnification. Cells lying within the region of interest (indicated by the purple 
contour) were counted, when they appeared in the counting frame and/or 
when they came into contact with the green line while lying outside the frame, 
unless they were crossed by the red line. In this case, cell A would be 
calculated, whereas the cell B would not, even if it were in focus. 
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Quality of stereological quantitative analysis can be assessed by 
estimating a coefficient of error (CE). The value of CE is calculated by 
dividing the standard error of the mean of repeated measurements by 
the mean (BIOSCIENCE, 2019b). CE is returned by the software in 
two so called smoothing classes: for m = 0 and m = 1. It is generally 
accepted to employ CE for m = 1 in biological samples, since it 
assumes that the shape of analysed region does not contain any 
abrupt changes (GUNDERSEN & JENSEN, 1987; GUNDERSEN et 
al., 1999). Moreover, to further evaluate the study design, the 
coefficient of variation (CV) was calculated as the standard deviation 
divided by the mean. In this case, both intra-animal variability (CE) and 
inter-animal differences (CV) were assessed. 
For evaluation of the study design, they were expressed as 
[CE2/CV2] and values ≤ 0.5 were considered acceptable 
(GUNDERSEN, 1986; RAJKOWSKA et al., 2016). Tables 2-4 
enclose the information regarding the quality of the quantification for 
HSPA1 (Table 2), HSPA5 (Table 3) and HSPH4 (Table 4). 
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Hil CA3 CA1 Ent PRh 
Mean HSPA1 cells 4084.7 13172.6 8862.1 22089.6 17156.8 
SD 4330.3 24653.4 17356.8 32542.1 31456.6 
Mean CE (m=0) 0.456 0.400 0.398 0.398 0.447 
Mean CV 1.060 1.872 1.959 1.473 1.833 
CE2/CV2 0.185 0.046 0.041 0.073 0.059 
Frame size (µm²) 2025 2025 2025 2025 4225 
Grid size (µm²) 14400 19600 19600 32400 62500 
Average Sections 5.1 5.1 5.1 5.1 5.0 
 Pir1 Pir2 Pir3 Amy Thal Pt 
Mean HSPA1 cells 1655.8 29835.1 9952.2 12622.4 61999.3 24200.2 
SD 2195.0 53478.9 17138.3 25594.0 119297.1 45894.0 
Mean CE (m=0) 0.544 0.482 0.414 0.582 0.433 0.509 
Mean CV 1.326 1.792 1.722 2.028 1.924 1.896 
CE2/CV2 0.169 0.072 0.058 0.082 0.051 0.072 
Frame size (µm²) 4900 625 4225 3600 3600 1607 
Grid size (µm²) 40000 25600 40000 78400 202500 77297 
Average Sections 6.5 6.5 6.3 3.1 5.0 4.1 
Table 2. Estimates of HSPA1 sampling parameters. Precision parameters for 
HSPA1 cell count for each region of interest: HSPA1 cells estimated count 
(mean value), standard deviation (SD), Gundersen coefficient of error second 
derivative (CE), mean inter-animal coefficient of variation (CV = SD/mean), 
CE2/CV2 ratio, optical fractionator frame and grid size, average number of 
sections analysed. 
  
80 
 
Hil CA3 CA1 Ent 
Mean HSPA5 cells 27832.2 95283.4 114747.5 185469.5 
SD 16649.2 61177.5 76727.0 183515.4 
Mean CE (m=0) 0.158 0.125 0.110 0.131 
Mean CV 0.455 0.591 0.617 0.908 
CE2/CV2 0.120 0.045 0.032 0.021 
Frame size (µm²) 2500 2500 2500 3600 
Grid size (µm²) 29929 58564 65025 116480 
Average Sections 11.8 11.3 11.5 11.6 
 PRh Pir1 Pir2 Pir3 
Mean HSPA5 cells 83558.9 9985.5 66784.2 67119.3 
SD 56794.9 7820.5 31398.2 41184.9 
Mean CE (m=0) 0.112 0.255 0.115 0.134 
Mean CV 0.635 0.711 0.444 0.565 
CE2/CV2 0.031 0.129 0.067 0.056 
Frame size (µm²) 3600 1600 1600 3600 
Grid size (µm²) 80080 22500 31684 81796 
Average Sections 11.9 12.2 12.2 12.2 
Table 3. Estimates of HSPA5 sampling parameters. Precision parameters for 
HSPA5 cell count for each region of interest: HSPA5 cells estimated count 
(mean value), standard deviation (SD), Gundersen coefficient of error second 
derivative (CE), mean inter-animal coefficient of variation (CV = SD/mean), 
CE2/CV2 ratio, optical fractionator frame and grid size, average number of 
sections analysed. 
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Hil CA3 CA1 Ent 
Mean HSPH4 cells 29441.9 78226.0 41995.9 154500.2 
SD 15321.5 54355.3 29222.2 95614.2 
Mean CE (m=0) 0.146 0.120 0.149 0.136 
Mean CV 0.854 0.984 0.923 0.949 
CE2/CV2 0.029 0.015 0.026 0.020 
Frame size (µm²) 2500 2500 2500 3600 
Grid size (µm²) 29929 58564 65025 173056 
Average Sections 10.9 11.1 11.6 11.1 
 PRh Pir1 Pir2 Pir3 
Mean HSPH4 cells 46780.4 4271.7 68101.2 73472.0 
SD 35725.7 2306.1 33772.7 36953.8 
Mean CE (m=0) 0.148 0.289 0.104 0.106 
Mean CV 1.018 0.942 0.945 0.933 
CE2/CV2 0.021 0.094 0.012 0.013 
Frame size (µm²) 3600 1600 1600 3600 
Grid size (µm²) 78400 22500 31684 81796 
Average Sections 11.2 11.8 11.7 11.7 
Table 4. Estimates of HSPH4 sampling parameters. Precision parameters for 
HSPH4 cell count for each region of interest: HSPH4 cells estimated count 
(mean value), standard deviation (SD), Gundersen coefficient of error second 
derivative (CE), mean inter-animal coefficient of variation (CV = SD/mean), 
CE2/CV2 ratio, optical fractionator frame and grid size, average number of 
sections analysed. 
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4.2. Colocalisation analysis 
4.2.1. HSPA1 
Immunofluorescent micrographs were acquired by means of confocal 
laser scanning microscopy with a confocal laser scanning microscope 
equipped with argon (458, 488, 514 nm), DPSS 561-10 (405 nm) and 
a HeNe633 (633 nm) lasers. Some samples were scanned using 
Airyscan principle, a method combining 32 optical detectors (each 
representing 0.2 Airy unit) with a further deconvolution step to produce 
a superresolution image (KOROBCHEVSKAYA et al., 2017). Images 
were captured at resolution of 1024 x 1024 pixels with pixel dwell 2.02 
px/µs and double averaging of a single focal plane. The confocal 
images were obtained using a Plan-Apochromat 20x/0.8 NA and Plan-
Apochromat 63x/1.4 NA objective. For image processing, Zeiss built-
in software (ZEN software) was utilised. All samples have been 
inspected in all regions of hippocampus (CA1, CA3, Hil) as well as the 
parahippocampal cortices (PRh, Pir), both ipsilaterally and 
contralaterally (respectively to the electrode location), to evaluate 
colocalisation of heat shock proteins with labelling for cell markers. In 
all of above regions, at least one single-plane picture was acquired. In 
some regions z-stack imaging was performed. 
Two quantitative approaches were used to evaluate signal 
colocalisation. In HSPA1/GFAP and HSPA1/NeuN staining the shape 
of colour intensity scatterplot was inspected. ZEN software returns 
such plots in its “Colocal” function, allowing to estimate the amount of 
colocalising pixels. In case of colocalisation, one can observe a more 
or less scattered cloud in the third quadrant of the plot (Fig. 6), while 
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lack of colocalisation leaves two clouds of points aligned along x- and 
y-axis (quadrant 1 and 2). This method is known and widely utilised in 
flow cytometry and has also its use in image analysis (DUNN et al., 
2011). To exclude the background signal, three different regions 
visually assessed as background were used to estimate thresholds for 
both compared channels using ZEN software’s hairline bisector 
method. Additionally to a scatterplot, the software also highlights 
colocalising pixels in the image. This can be exported as an 8-bit mask 
and merged with the original image to indicate the exact location of 
given pixels. 
Analysis of HSPA1, TLR4 and Iba1 was performed at high 
magnification (63x) by means of a Coloc2 plugin for ImageJ. This 
software expansion, in addition to plots described above, returns 
several values describing colocalisation in wide extent. The ones used 
in this analysis were Pearson correlation coefficient (PCC), used 
broadly as a measure of a strength of association between two 
variables, and intensity correlation quotient, described for 
fluorescence colocalisation specifically (LI et al., 2004; DUNN et al., 
2011). PCC values range between -1 and +1, where PCC = +1 means 
a perfect linear relation between fluorescence intensities, PCC = -1 – 
inverse relation and PCC = 0 – lack of correlation. ICQ derives from 
PCC and measures the extent in which intensities vary around their 
respective mean (LI et al., 2004). The value range varies between -
0.5 and +0.5, where -0.5 ≥ ICQ > 0 define a segregated staining, ICQ 
≈ 0 defines a random (or mixed) staining, and 0 < ICQ ≤ +0.5 defines 
a dependent staining. At least three regions of interest encompassing 
TLR4-positive cells were traced in each picture, returning values for 
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PCC and ICQ. The mean for each region in each animal was 
calculated. A cut off value of 0.5 for PCC and of 0.25 for ICQ for 
colocalisation purposes. 
 
Figure 6. Colocalisation estimation, using the scatterplot method. In the 
diagram, each dot represents a value of red and green intensities for each 
pixel (X-axis: red signal, Y-axis: green signal). If a pixel demonstrates a 
colocalising signal of both colours, it is located in the quadrant 3 of the scatter 
plot. Continued on page 85.  
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Figure 6. Continued. Pixels showing purely red signal belong to the quadrant 
1, while green ones – to the quadrant 2. Quadrant 4 gathers the information 
about the pixels from the background. 
4.2.2. HSPA5 and HSPH4 
Confocal laser scanning microscopy was performed, employing the 
same hardware as described above. Images were captured at 
resolution of 1024 X 1024 pixels with pixel dwell 2.02 px/µs and in 
order to improve the signal-to-noise ratio, two scans of one focal plane 
were averaged. Images were obtained using Plan-Apochromat 
20x/0.8 NA and Plan-Apochromat 63x/1.4 NA objectives, then further 
processed with ZEN software. 
All animals were visually inspected in hilus, CA1, CA3, perirhinal and 
piriform cortices to assess and locate the presence of HSPH4 and 
HSPA5 labelled cells. Where signal was located, 5 to 7 single confocal 
plane representative images were acquired at low magnification both 
in ipsilateral and contralateral hemispheres. In case the probes signal 
was not clearly identifiable, both higher magnification and z-stack 
micrographs were captured in order to increase image resolution. 
To analyse colocalisation of HSPA5 and GFAP in detail, low 
magnification (20x) pictures were processed by ZEN software (Blue 
edition) and investigated by means of the abovementioned “Colocal” 
function of the program. Briefly, contours of two selected cells in the 
field of view were traced and later on, their PCC was estimated. To 
set a threshold to differentiate a signal from the background noise, a 
built-in “Costes” function. This allows the software to set a threshold 
according to a statistical significance test developed by Costes – it 
evaluates the probability that the calculated value of PCC between the 
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two channels of interest is significantly greater than values of PCC 
measured in randomly overlapping pixels (COSTES et al., 2004). This 
approach removes the bias of visual interpretation and allows 
automatisation of the thresholding process. 
PCC measured based on cells’ signal was afterwards expressed as a 
mean value for each group of animals. A cut-off threshold of PCC = 
0.5 was set to distinguish the colocalising signal from randomly 
overlapping pixels. 
4.3. Optical density 
Since canine tissue samples were taken from animals post mortem, a 
highly standardised tissue sampling procedure as the one carried out 
in rats was not possible. For this reason, a stereological cell count 
could not be performed and instead levels of HSPA5 and HSPH4 were 
quantified by means of optical density (OD) and area of the staining 
for these two proteins. 
Images were captured at 20x magnification using a brightfield 
microscope equipped with a single chip charge-coupled device (CCD) 
colour and an AMD Athlon 64 processor based computer with image 
capturing software. Images were analysed by ImageJ software as 
described by SCHNEIDER et al. (2012). 
Regions of interest included hippocampal dentate gyrus (DG), hilus, 
CA1, CA3 and parahippocampal cortex (PHC). Due to lack of 
standardised sources regarding detailed anatomy of canine brain, 
PHC has not been divided into subregions, unlike in rats. In each 
region, five representative pictures were acquired at 40x 
magnification, resulting in up to 25 visual fields (297.22 x 222.70 µm) 
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obtained from each animal. 
For optical density analysis, at first we performed calibration in 
accordance with instructions on the software website (IMAGEJ). 
Images were then analysed as follows: initially pictures were cropped 
to contain only the region of interest and exclude artefacts. Afterwards, 
images were processed with the colour deconvolution plugin (vector 
Hematoxylin-DAB) described by RUIFROK and JOHNSTON (2001) 
that generates three 8-bit images (brown, blue and green), of which 
only the brown one, corresponding to DAB, was further processed. 
Histogram-based automatic triangle threshold (ZACK et al., 1977) was 
applied to images in order to select specific signal over the 
background. Thresholded area and mean OD values from all pictures 
analysed were averaged for each region and further used for statistical 
analysis. 
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5. Statistics 
Statistical analysis was performed with GraphPad Prism 5.04. 
Estimated cell counts from each time point in all regions, as well as 
the volumes calculated by the Stereo Investigator software were 
compared between the ipsilateral and contralateral site using a one-
way analysis of variance (ANOVA) followed by Bonferroni post hoc 
test. Cell density in HSPA1, HSPA5 and HSPH4 immunostaining was 
compared between SE and control animals in all regions within each 
time point by using the unpaired Student’s t-test. Data are presented 
as a mean ± SEM and a p value < 0.05 is considered statistically 
significant. 
Optical density and positive area in HSPA5 and HSPH4 in dogs was 
conducted using a one-way ANOVA with a Bonferroni post hoc test to 
indicate differences between particular groups. 
In the 2d post-SE time point, HSPA1-NeuN colocalisation area was 
analysed using a one-way ANOVA in order to compare the difference 
of colocalisation levels in relevant hippocampal (hilus, CA3, CA1) and 
parahippocampal (perirhinal cortex, piriform cortex) regions. 
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V.  RESULTS 
1. HSPA1 expression in the rat model of 
epileptogenesis 
The analysis of immunohistochemically stained brain tissue provided 
comprehensive information about HSPA1 expression pattern in 
regions relevant for epileptogenesis. On a cellular level, HSPA1 signal 
was predominantly distributed in the soma, with some cells expressing 
the protein also in axons and dendrites. Control animals showed 
sparse HSPA1-positive cells in all investigated brain areas at every 
time point. Similar pattern has been observed in samples from status 
epilepticus animals in the latency phase and in the chronic phase with 
SRSs. In the early post-SE phase the staining was much more 
intense, with higher number of positive cells (assessed visually), but 
also with intensified specific diffuse signal in hilus and in CA3 as well 
as, to less extent, in CA1 subregions of the hippocampus (Fig. 7F). 
Stained cells were located mainly in the pyramidal layer of CA1 and 
CA3 and morphologically resembled neurons. Diffuse expression 
localised in regions neighbouring to the pyramidal layer, namely 
stratum lacunosum-moleculare, stratum radiatum, stratum lucidum 
and the stratum oriens. 
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1.1. HSPA1 expression levels in the course of 
epileptogenesis 
Ipsilateral and contralateral cell counts revealed no difference 
between the both sides for all evaluated groups, therefore the total cell 
number from them was summed up, so for further analyses a single 
value represented each region in each animal. The electrical insult 
elicited the strongest effect on the expression of HSPA1 in the early 
post-SE phase, a milder and more localised effect in the latency phase 
and no significant effect in the chronic phase of the epileptogenesis. 
Older animals tended to exhibit a higher overall HSPA1 expression.  
 
 
 
 
Figure 7. Quantification of HSPA1 cellular expression in hippocampus, 
thalamus and amygdala. Cell density of HSPA1 stereological cell count in (A) 
hilus, (B) CA3, (C) CA1, (D) thalamus and (E) amygdala. Each data point 
represents cell density of the counts from ipsilateral and contralateral sides 
summed together. Low magnification representative images of the 
hippocampus and the parahippocampal cortex from the early post-insult 
phase are presented in (F). HSPA1 signal in SE animals is intense compared 
to controls. Cell soma as well as processes are visible. A diffuse pattern is 
also present in the hilus and CA3 and to lesser extent in CA1. All data are 
presented as mean (dashed line) ± SEM, * p < 0.05, paired Student’s t-test for 
each time point. CTR: electrode implanted controls, SE: electrically stimulated 
animals, 2d: two days post-SE, 10d: 10 days post-SE, 8w: 8 weeks post-SE. 
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Figure 7. Description on page 90. 
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The most prominent effect was observed in the hippocampus, 
showing significant upregulation of HSPA1 expression in the acute 
phase in all regions. Stimulated animals showed a 23-fold increase (p 
= 0.0017; Fig. 7A) in HSPA1 positive cells in the hilus, a 30-fold 
increase (p < 0.0001; Fig. 7B) in CA3 and a 41-fold increase (p = 
0.0070; Fig. 7C) in CA1. In the parahippocampal cortex, HSPA1 
overexpression was evident two days following SE, but with a milder 
effect in comparison to the one observed in the hippocampus. The 
strongest effect has been observed in the perirhinal cortex and in the 
third layer of the piriform cortex, which lasted also in the latency phase. 
In PRh a 17-fold increase (p < 0.0001; Fig. 8A) in HSPA1 positive cells 
was found between animals in the early post-SE phase compared to 
respective controls. A 5-fold increase (p = 0.0083) in cell density was 
found ten days following SE. A similar pattern was also found in the 
Pir3, where HSPA1-positive cell density presented a 18-fold increase 
(p < 0.0001; Fig. 8D) 2 days after SE and a 4-fold increase (p = 0.0270) 
10 days after SE. A moderate effect was visible in other layers of the 
piriform cortex with a 12-fold increase (p < 0.0001; Fig. 8C) in the 
second layer and a 3-fold increase (p = 0.0037; Fig. 8B) in the first 
layer in the early post-insult phase. At the same time point, the 
analysis revealed a 10-fold increase in the entorhinal cortex (p < 
0.0001; Fig. 8D). In the parietal association cortex, a strong effect was 
visible only in the early post-insult phase with a 48-fold increase of the 
HSPA1 cell density (p < 0.0001; Fig. 8F). A distinctive effect was 
visible also in other associated brain areas: in the thalamus a 35-fold 
increase (p = 0.0042; Fig. 7D) was observed, while the effect was 
milder in the amygdala with a 12-fold increase (p < 0.0001; Fig. 7E) in 
V. Results  93 
HSPA1 positive cells. 
 
Figure 8. Description on page 94. 
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Figure 8. Quantification of HSPA1 cellular expression in the parahippocampal 
and parietal cortices. Cell density of HSPA1 stereological cell count in (A) 
perirhinal cortex, (B) piriform cortex layer 1, (C) piriform cortex layer 2, (D) 
piriform cortex layer 3, (E) entorhinal cortex and (F) parietal cortex. All data 
are presented as mean (dashed line) ± SEM, * p < 0.05, paired Student’s t-
test for each time point. CTR: electrode implanted controls, SE: electrically 
stimulated animals, 2d: two days post-SE, 10d: 10 days post-SE, 8w: 8 weeks 
post-SE. 
1.2. Profiling of HSPA1 expression in various cell 
types 
Double and triple fluorescent immunolabelling provided a 
comprehensive overview of expression on a cellular level. Double 
staining of HSPA1 with the marker for neuronal nuclei (NeuN) 
revealed colocalisation of signal from both molecules in all considered 
regions (Fig. 9). Neuronal expression of HSPA1 was present in 
animals from both, SE and control groups. The area of colocalisation 
(Fig. 10) varied however among regions with higher levels in 
stimulated animals than in the controls. This however should be 
interpreted considering the overall lower number of HSPA1 
immunopositive cells in the control animals. 
Double immunofluorescent labelling for HSPA1 and astrocytic marker 
GFAP demonstrated no colocalisation in the pixel-by-pixel analysis of 
both signals (Fig. 11). This suggests no relevant expression of HSPA1 
in astrocytes in relevant regions at given time points. Few colocalising 
dots present in cells are rather an indication of a local contact between 
astrocytes and HSPA1-positive cells (presumably neurons), which 
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suggests analysis of Z-stacked pictures acquired at high magnification 
(63X). 
Triple immunofluorescent staining involving markers for HSPA1, TLR4 
and microglia (Iba1) revealed a strong colocalisation of the first two 
(PCC = 0.74, ICQ = 0.31, n = 33; Figure 11). Interactions between 
Iba1 and HSPA1 were found to be much weaker (PCC = -0.16, ICQ = 
0.06, n = 33), indicating no biologically relevant expression of HSPA1 
in microglia. Similar correlation was observed also for the interaction 
between TLR4 and Iba1 (PCC = -0.21, ICQ = 0.05, n = 33). Microglial 
cells visualised by the staining were found in the near vicinity of 
HSPA1 expressing cells, and they morphologically appeared to be in 
an activated state (larger cell bodies, shorter processes as compared 
to control animals). Some of activated microglial cells engulfed 
HSPA1-positive cells, suggesting a direct contact between them. 
 
 
 
Figure 9. Neuronal expression of HSPA1. Low magnification (20x) 
representative microphotographs of the subregions of the hippocampus and 
the parahippocampal cortex. For each region are presented: A - HSPA1 
positive cells in red, B - NeuN positive cells in green, C - the merged image 
with Hoechst 33342 superimposed with the colocalisation white mask and D - 
colocalisation scatterplot computed by the software. The scatterplot is typical 
for two colocalising probes presenting a big cloud of colocalising pixels in the 
quadrant 3 (top right), which corresponds to the white area mask visible in the 
column C. 
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Figure 9. Description on page 95. 
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Figure 10. Comparison of area of colocalisation in the HSPA1/NeuN staining. 
Each dot represents a value for one animal from a given group. SE animals 
show higher area of colocalisation (following the overall trend of higher 
HSPA1-positive cell amount), but they also demonstrate a higher variance 
than controls. In some regions of interest (piriform and perirhinal cortex), no 
HSPA1-positive cells were observed. 
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Figure 11. Lack of astroglial expression of HSPA1. Low magnification (20x) 
representative microphotographs of the hippocampus and the 
parahippocampal cortex. Continued on page 99.   
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Figure 11. Continued. For each region are presented in columns: A - HSPA1 
positive cells in red, B - GFAP positive cells in green, C - the merged image 
with Hoechst 33342 superimposed with the colocalisation white mask and D - 
colocalisation scatterplot computed by the software. The scatterplot is typical 
for two independent, not colocalising probes presenting a scarce single 
colocalising pixels in the quadrant 3 (top right), which corresponds to the white 
area mask visible in the column C. Pixels located in the quadrant 1 represent 
an exclusive red signal of HSPA1 while the ones in the quadrant 2 – an 
exclusive green signal of GFAP. 
 
 
 
 
 
 
 
 
Figure 12. Colocalisation of HSPA1 with its receptor (TLR4) and lack of 
HSPA1 expression in the microglia. High magnification representative 
microphotographs of triple immunolabelled cells in the perirhinal cortex. Merge 
image (A) of single channels for HSPA1 (B), TLR4 (C) and Iba1 (D) with a 
region of interest of three cells overlayed. An example of colocalisation 
analysis (E) where for each marker combination (first row: HSPA1/TLR4; 
second row: HSPA1/Iba1; third row: Iba1/TLR4) is presented a scatterplot 
relative to the region of interest (Cells #1-3). 
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Figure 12. Description on page 99. 
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2. HSPA5 and HSPH4 expression in 
epilepsy  
2.1. Rat model of epileptogenesis 
This study aimed to describe the expression profile of the cognate of 
HSPA8 in the endoplasmic reticulum (HSPA5) and of its cochaperone 
(HSPH4) in the course of epileptogenesis in the rat electrical SE 
model. Immunohistochemical staining revealed information about their 
distribution in the investigated regions. The staining pattern was 
similar in both SE and control animals, with HSPA5 signal distributed 
predominantly in cell soma. The signal was present mostly in the close 
vicinity to the cell nucleus (as expected of the protein present in the 
ER), but also in cytosol, reaching in some cases into the processes 
(Fig. 13I-L). HSPH4 followed the somatic expression pattern (Fig.14I-
P), but diffused also in the extracellular matrix in stratum lacunosum-
moleculare, stratum radiatum, stratum lucidum and stratum oriens of 
the Cornu Ammonis. 
No differences in the cell count nor in the volume analysis were 
observed between the hemispheres, so the numbers from the 
contralateral and ipsilateral sides were summed up and expressed as 
cell density (cell number over volume) in a single number representing 
a value for each region in each animal, analogically to the analysis of 
HSPA1. The effect of status epilepticus on the expression of both 
proteins was seen mostly in the latency phase. In the acute phase the 
effect of the stimulation was marginal and no difference was observed 
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in the chronic phase with spontaneous recurrent seizures. 
 
Figure 13. Description on page 103.  
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Figure 13. Quantification of the cellular expression of HSPA5 in rat. Cell 
density of HSPA5 stereological cell counting in the hippocampus (A: hilus, B: 
CA1, C: CA3) and parahippocampal cortices (D: entorhinal cortex, E: piriform 
cortex layer 1, F: piriform cortex layer 2, G: piriform cortex layer 3, H: perirhinal 
cortex). Each data point represents cell density of the counts from the 
ipsilateral and contralateral sides summed together. Representative images 
of piriform cortex illustrating the increase of HSPA5 positive cells in SE (J, L) 
compared to control animals (I, K). All data are presented as mean (dashed 
line) ± SEM, * p < 0.05, paired Student’s t-test for each time point. CTR: 
Electrode-implanted controls, SE: electrically stimulated animals, 2d: two days 
post-SE, 10d: 10 days post-SE, 8w: 8 weeks post-SE 
HSPA5 
The analysis of the density of HSPA5-positive cells revealed 
upregulation of protein expression in SE animals in the 
parahippocampal cortex, specifically in the piriform cortex layer 1, 
during the acute post-insult phase (3.5-fold increase; t(5) = 3.773, p = 
0.013; Fig. 12E) and in the latency phase (3.6-fold increase; t(5) = 
2.903, p = 0.0337; Fig.13E). Since anterior and posterior segments of 
the piriform cortex are known to exhibit differences in histology and in 
function (the ventrorostral part of Pir incorporates a distinct 
chemoconvulsant trigger zone, low in GABAergic inputs of inhibitory 
neurons, called area tempestas), cell counting results were analysed 
separately for both parts of the region. Lateral olfactory tract was 
employed as an anatomical indicator of the anterior Pir according to 
LOSCHER and EBERT (1996). In the acute phase, immunostained 
cell density was increased in SE animals in comparison to controls 
(t(5) = 3.035, p = 0.0289; data not shown) in the anterior piriform 
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cortex. In the latency phase (10 days after SE), the increase in positive 
cell number was significant in status epilepticus rats compared to 
control animals (t(5) = 3.33, p = 0.0208) in the posterior part of Pir, 
with a strong trend towards significance in the anterior moiety. The 
other layers of the piriform cortex, as well as other regions of interest 
in the rat brain, did not demonstrate any significant differences related 
to the status epilepticus (Figure 13A-D, F-H). 
HSPH4 
Quantification of HSPH4 revealed a more distinct influence of SE on 
protein expression, both in the hippocampus, and in the 
parahippocampal cortex. This effect was however present exclusively 
in the latency period. Among hippocampal regions, the upregulation 
was pronounced in the CA1 with a 1.7-fold increase in the SE animals 
as compared to controls (t(8) = 2.381; p = 0.0445; Fig.14B). In the 
parahippocampal cortex, HSPH4 expression was found to be 
upregulated in the entorhinal (1.9-fold; t(9) = 3.511; p = 0.0066; Fig. 
14D), in the perirhinal (2.3-fold; t(9) = 3.663; p = 0.0052; Fig.14H) and 
in the piriform cortex layer 2 (1.6-fold; t(9) = 3.456; p = 0.0072; 
Fig.14F). No significant difference has been observed in the remaining 
regions of the temporal lobe (Fig.14A, C, E, G). 
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Figure 14. Quantification of the cellular expression of HSPH4 in rat. Cell 
density of HSPH4 stereological cell counting in the hippocampus (A: hilus, B: 
CA1, C: CA3) and parahippocampal cortices (D: entorhinal cortex, E: piriform 
cortex layer 1, F: piriform cortex layer 2, G: piriform cortex layer 3, H: perirhinal 
cortex). Each data point represents cell density of the counts from the 
ipsilateral and contralateral sides summed together.  Continued on page 106. 
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Figure 14. Continued. All data are presented as mean (dashed line) ± SEM, * 
p < 0.05, paired Student’s t-test for each time point. CTR: Electrode-implanted 
controls, SE: electrically stimulated animals, 2d: two days post-SE, 10d: 10 
days post-SE, 8w: 8 weeks post-SE. 
2.2. HSPA5 and HSPH4 profiling in various cell 
populations 
To characterise which types of brain cells express heat shock proteins 
of interest, we performed immunofluorescent double labelling of 
HSPA5 and HSPH4 with common neural and glial cell markers: NeuN, 
GFAP and Iba1 in the subregions of rat hippocampus and 
parahippocampal cortex. 
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Figure 15. HSPA5 expression in various brain cell populations. 
Representative microphotographs (20x, digital zoom 2x) of double 
immunostaining of HSPA5 (A, D, G) with NeuN (B), Iba1 (E) and GFAP (H) 
respectively. In the merged images (C, F, I), with Hoechst 33342 counterstain 
visible in blue, it is possible to observe the protein’s colocalisation with a 
neuronal marker (C) but not with a microglia marker (F). Colocalisation of 
HSPA5 with GFAP is restricted to several cells in the layer 1 of the piriform 
cortex (I). 
The visual inspection of the immunostaining revealed colocalisation of 
HSPA5 with a neuronal marker (NeuN; Fig.15A-C) in all groups of 
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animals with the distribution of the heat shock protein in the close 
vicinity to the cell nucleus counterstained with Hoechst 33342. On the 
other hand, signal from a microglial marker (Iba1; Fig.15D-F) did not 
colocalise with the one of HSPA5 neither in SE nor in control animals. 
Double immunolabelling of HSPA5 with an astrocytic marker (GFAP; 
Fig.15G-I) demonstrated single scarce cells present in layer 1 of the 
piriform cortex (1-4 in the field of view) exhibiting colocalisation of the 
two proteins (Fig.16). The colocalisation could be detected 
predominantly in SE animals in the acute post-insult phase. 
Interestingly, in other regions this trend could not be confirmed and 
only neuronal expression of HSPA5 was observed. 
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Figure 16. HSPA5 expression in cortical astrocytes. A representative high 
magnification Z-stack image demonstrating colocalisation of HSPA5 and 
astroglial marker GFAP within a cell in the piriform cortex layer 1 in a SE 
animal in the early post-insult phase. Several cells in the same region in the 
same group of animals presented a similar expression pattern. 
These findings were confirmed by quantification of PCC of both 
signals in HSPA5/GFAP double staining (Table 5). The cut-off value 
of PCC = 0.5 was exceeded only in the piriform cortex in SE animals 
during the early post-insult phase. Results of other groups oscillated 
around PCC = 0, indicating no correlation between the signals of 
HSPA5 and GFAP, and thus – no colocalisation. 
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    Hilus CA3 CA1 PRh Pir 
2d 
CTR 0.10 0.04 -0.01 0.19 0.51 
SE 0.00 0.00 -0.05 0.01 0.05 
10d 
CTR -0.14 0.00 -0.04 -0.07 0.23 
SE 0.00 0.00 0.14 0.09 0.04 
12w 
CTR 0.23 -0.15 -0.01 -0.06 0.05 
SE 0.05 0.03 0.08 0.00 -0.17 
Table 5. Results of colocalisation analysis in HSPA5/GFAP staining. Reported 
are values for Pearson’s correlation coefficient in different groups in all the 
time points in five investigated regions. Only SE animals showed temporally 
and regionally restricted expression of HSPA5 in astroglia. Threshold value 
for PCC indicating colocalisation was set for PCC = 0.5. 
Double immunofluorescent staining of HSPH4 with NeuN (Fig.17A-C) 
also revealed colocalisation between the two markers in all 
investigated regions. HSPH4 signal presented more cytoplasmic 
localisation as compared to the HSPA5 signal. No colocalisation 
between HSPH4 and Iba1 was observed (Fig.17D-F) and in contrast 
to HSPA5, the labelling of HSPH4 with GFAP did not demonstrate 
colocalisation of these two proteins (Fig.17G-I). The abovementioned 
trends were present in experimental as well as in control animals. 
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Figure 17. HSPH4 expression in various brain cell populations. 
Representative microphotographs of double immunostaining of HSPH4 (A, D, 
G) with NeuN (B), Iba1 (E) and GFAP (H) respectively. In the merged images 
(C, F, I), with Hoechst 33342 counterstain visible in blue, it is possible to 
observe the protein’s colocalisation with a neuronal marker (C), but neither 
with a microglia (F), nor with an astrocyte marker (I). 
2.3. HSPA5 and HSPH4 expression profiles in dogs 
The analysis of immunohistochemically stained canine brain tissue 
revealed a similar location of the HSPA5 signal as in rats: in the cell 
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soma, in close vicinity of the nucleus, suggesting an expression inside 
the ER (Fig.18E). The majority of positive cells was present in stratum 
pyramidale of CA1 and CA3 regions of hippocampus as well as in the 
hilus of the dentate gyrus. In the parahippocampal cortex, the most 
cell dense region was layer 2 of piriform cortex. The morphology of the 
majority of the stained cells showed similarity to pyramidal neurons 
and, sparsely, to astroglia. Nevertheless, no significant differences in 
optical density (data not shown) nor in stained area (Fig.18A-D, F) 
were found between different groups (data not shown). 
Immunohistochemical staining of HSPH4 also exposed a cytoplasmic 
signal, which however proved to be more diffuse than the one of 
HSPA5 (Fig.18H). The expression pattern was similar to the one of 
HSPA5, where the pyramidal layer of CA1 and CA3 as well as the 
hilus of dentate gyrus stood out as consisting the most positive cells. 
The cell morphology was in this case also reminiscent of pyramidal 
neurons, with the most signal gathered in the cell soma. The 
quantitative analysis considering the aetiology of the disease revealed 
a significant change in positively stained area in CA1 [F(3,43) = 5,569, 
p = 0,0045; Fig.17K]. Post hoc comparison between individual groups 
exposed area enlargement in animals with structural epilepsy as 
compared to the patient control group of 151%. A trend toward 
significant differences was observed in the molecular layer of dentate 
gyrus [F(3,42) = 2,495, p = 0,0729; Fig.18J]. 
The quantitative analysis of the positively stained area for cluster, 
status epilepticus and control groups revealed a significant difference 
in CA1 [F(2,44) = 3,31, p = 0,0459; data not shown]. Bonferroni’s 
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Multiple Comparison Test showed no statistically significant 
differences between respective groups. In CA3 and hilus a trend 
towards significance was observed [CA3: F(2,40) = 3,121, p = 0,055; 
Hil: F(2,43) = 2,75; p = 0,0752; data not shown]. No statistically 
significant difference was spotted between these groups in the 
analysis of OD (data not shown). 
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Figure 18. HSPA5 and HSPH4 quantification in canine tissue. Immunopositive 
area respectively for HSPA5 and HSPH4 in hilus (A, G), CA1 (B, K), CA3 (C, 
I), DG (D, J) and parahippocampal cortex (F, L). Data points correspond to 
averaged immunopositive area for HSPA5 and HSPH4 measured in each 
animal. Representative images of CA1 region staining for HSPA5 (E) and 
HSPH4 (H) in animals with structural epilepsy. All data are presented as mean 
(dashed line) ± SEM, * p < 0.05, one-way ANOVA with Bonferroni post hoc 
test. CTRexp: control dogs without neurological diseases used in 
parasitological studies. CTRpat: control dogs without neurological diseases 
treated in the clinic. Idiopathic: patients with idiopathic epilepsy, subtype 
unknown cause and no identification of structural epilepsy. Structural: patients 
with epilepsy caused by identified cerebral pathology. 
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VI. DISCUSSION 
The goal of this study was to describe the expression profiles of HSP 
family members during epileptogenesis, taking into consideration the 
development of the process and pathophysiological changes in its 
distinct phases. This description can be of use for further assessment 
of the proteins’ suitability as targets for anti-epileptogenic treatment as 
well as for finding a suitable time window for therapeutical approaches. 
Targeting HSPA1-mediated inflammatory signalling has already been 
proposed for several diseases (SAMBORSKI & GRZYMISLAWSKI, 
2015; BERNARDO et al., 2016; KIRKEGAARD et al., 2016; KUMAR 
et al., 2016; KIM et al., 2018), also for epilepsy (YENARI et al., 1998; 
YANG et al., 2008; HU et al., 2019). The characterisation of the 
expression pattern of two other heat shock proteins, HSPA5 and 
HSPH4, is relevant for better understanding of processes occurring in 
a specific cell compartment, namely in the endoplasmic reticulum, 
following status epilepticus. It also provides a bigger picture in terms 
of heat shock reaction and its possible consequences in the course of 
epileptogenesis. 
1. HSPA1 
Preliminary immunohistochemical staining performed in the large-
scale proteomics study in the electrical post-SE rat model in our lab 
provided evidence for an early induction of HSPA1 in the hippocampus 
and in the parahippocampal cortex following the insult (WALKER et 
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al., 2016). Detailed quantitative analysis of the regions relevant for the 
development of temporal lobe epilepsy confirmed these findings, and 
added specific information regarding changes in the expression 
following status epilepticus. All regions analysed showed a noticeable 
induction of HSPA1, with the effect especially pronounced in 
hippocampal subregions and in the piriform cortex, areas prone to 
neuronal cell damage as the consequence of SE. This regulation 
seems to be in accordance with the role of HSPA1 as an inhibitor of 
apoptosis (BENARROCH, 2011; KIM et al., 2018) and seems to act 
as a protective mechanism following the insult and the subsequent cell 
stress and damage. HSPA1 overexpression has already proven to 
exert neuroprotective effects and to increase neuronal survival in 
stroke and epilepsy models (YENARI et al., 1998). Chemical induction 
of SE triggers a rapid increase in HSPA1 expression rates in several 
studies (VASS et al., 1989; YANG et al., 2008; LIVELY & BROWN, 
2011). Those previous studies were not however based on unbiased 
stereological cell quantification, which was utilised in our project. The 
electric SE model used for purposes of this study excludes also 
possible direct effects of chemoconvulsants, providing unambiguous 
confirmation of findings in abovementioned experiments. 
The rapid induction of HSPA1 expression was observed in all regions 
of interest, the extended effect, lasting at least ten days, was however 
evident only in the layer 3 of the piriform cortex and in the perirhinal 
cortex. These findings suggest HSPA1-related signalling may play a 
role also in the latency phase of epileptogenesis, although its effect is 
limited anatomically. In general, HSPA1 expression seems to be 
declining with progression of the process of epileptogenesis, being 
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relevant only locally in some parahippocampal regions. This seems to 
be further confirmed by a lack of changes in expression rates during 
the chronic phase with spontaneous recurring seizures, when HSPA1 
levels in animals surviving SE show no difference in comparison to 
controls. This stays in line with results of the large-scale proteomic 
analysis performed in the same model (WALKER et al., 2016). 
In total, the findings argue against a prolonged relevant functional role 
of HSPA1 after single seizure event. Earlier analysis of human tissue 
from patients with temporal lobe epilepsy revealed only scarce 
HSPA1-positive cells (YANG et al., 2008; NAKAYAMA et al., 2017). 
Also in brain samples from canine epileptic patients, HSPA1 levels 
were changed to low extent solely in the piriform cortex, while 
hippocampus remained unaffected (VON RUDEN et al., 2020). Thus, 
both experimental and clinical data suggest that the cellular events 
associated with recurrent short single seizures present in the chronic 
phase seem to be insufficient to trigger HSPA1 upregulation. In 
general, the most suitable time point for targeting HSPA1-related 
processes seems to be the early phase following the insult. 
Nevertheless, further studies would be necessary to indicate a 
suitable time window within the post-insult phase, especially since 
HSPA1 upregulation has been already described to be significant in a 
period of 24 hours after SE in the kainate model (CHANG et al., 2014). 
To better understand the role of HSPA1 in the epileptogenic process, 
it is crucial to describe pathology-associated regulation of its 
expression in various cell populations. We decided to analyse the 
overall neuronal population as well as glial cell types most relevant for 
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neuroinflammation, namely microglia and astrocytes. 
Immunohistochemical analysis of double and triple labelled cells 
revealed a predominant induction of HSPA1 expression in neurons. 
These results stay in line with findings from chemically induced post-
SE rat models, which also described neuronal overexpression (VASS 
et al., 1989; YANG et al., 2008; LIVELY & BROWN, 2011). It has 
already been suggested for HMGB1 that neuronal cell stress might 
serve as the first trigger for enhanced DAMP signalling following an 
epileptogenic insult (PAUDEL et al., 2018). Release of danger signals 
from injured cells can afterwards signal via Toll-like receptors and 
mediate an excessive response of the innate immune system. The 
resulting pro-inflammatory signalling events seem to contribute to 
epileptogenesis. As HSPA1 is known to serve as a ligand of TLR4 
receptors, it might modulate respective molecular responses occurring 
during the early phase following a brain insult. 
In contrast to the pronounced induction in neurons, we did not obtain 
evidence for a relevant regulation in astrocytes and only observed a 
very weak expression in microglia. On the one hand, it might give an 
impression that activation of glia cells does not influence HSPA1 
expression rates following SE. However, considering the half-life of 
the protein of approximately 18 hours (GERNER et al., 2002) and the 
promptitude of HSPA1 response (CLOUTIER & COULOMBE, 2013; 
CHANG et al., 2014), it is plausible that we analysed cells after the 
peak of their HSPA1 expression. Furthermore, different types of 
stressors seem to cause different patterns of cellular HSPA1 
regulation. For instance, the analysis following hyperthermia induced 
in rats revealed a more intense upregulation of HSPA1 in microglia as 
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compared to neurons and astrocytes (PAVLIK & ANEJA, 2007). 
Inducible form of HSPA1 was also reported to be expressed mostly in 
neurons and not to be expressed in astrocytes in a rat stroke model 
(AGULLA et al., 2013). Henceforth, the cellular pattern of HSPA1 
expression seems to depend on the type of insult and glial cells might 
be less responsive to the stress associated to status epilepticus than 
neurons. 
To understand why HSPA1 expression is so significant in neurons, 
one has to consider pathophysiology of a seizure. Prolonged 
hyperactivity of excitatory neurons leads to prominent glutamate 
release. Following extended NMDA receptor signalling can result in a 
cell stress, which can serve as a trigger for the induction of HSPA1. 
The protein is known to protect hippocampal neurons from excessive 
extracellular glutamate with subsequent excessive activation of NMDA 
receptors (AYALA & TAPIA, 2008). However, there seems to be a link 
between HSPA1 expressing neurons and microglial cells, which is 
indirectly supported by the presence of microglia in close proximity of 
HSPA1/TLR4 immunopositive cells. Furthermore, these microglial 
cells exhibit a morphology reflecting an activated state and in several 
cases they seem to engulf HSPA1-expressing neurons, advocating for 
a putative influence of neuronal HSPA1 expression on glial cells in 
their vicinity. 
Whether HSPA1 overexpression leads to any functional 
consequences, remains an open question. Intracellular HSPA1 is 
believed to have an important role in neuroprotection, since its 
expression can limit generation of pro-inflammatory mediators and 
120 
reactive oxygen species (KIM & YENARI, 2013). At the same time, 
extracellular HSPA1 is a well-known ligand of Toll-like receptors 2 and 
4, of which TLR4 cascade is a relevant contributor to seizure 
generation. It still remains unknown, whether HSPA1 serves as an 
agonist, an antagonist, or partial agonist/antagonist of TLR4, and 
results regarding this matter so far are contradictory (ASEA et al., 
2000; ASEA et al., 2002; SINGLETON & WISCHMEYER, 2006; 
FERAT-OSORIO et al., 2014). Recent studies reported that HSPA1 
induction during seizures leads to proteasomal degradation of Kv4-
KChIP4a channel complexes responsible for generating a neuronal A-
type current (HU et al., 2019). A-type channels are activated in 
response to hyperpolarisation and their activity tends to delay the 
following depolarisation. Their degradation can therefore lead to 
shortening of the period between the action potentials. This may serve 
as a link between overexpression of HSPA1 and pathophysiology of 
epileptogenesis. The HSPA1-mediated proteasomal degradation of 
potassium channel complex might also occur during early phases of 
epileptogenesis thereby contributing to network reorganisation and 
changes leading to hyperexcitability. 
The functional impact of HSPA1 in the generation of a hyperexcitable 
network was studied extensively in our working group. Two 
experiments were performed, encompassing genetic and 
pharmacological regulation of HSPA1 expression. Findings from 
knockout mice lacking inducible HSPA1 showed increased seizure 
thresholds, more severe seizures, and enhanced microglia activation, 
which supports a protective role of the protein. However, treatment 
with the HSPA1 inducing compound celastrol as well as HSPA1 
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overexpression in mice lines also increased seizure severity (VON 
RUDEN et al., 2018; VON RUDEN et al., 2019). 
In summary, as mentioned above, the putative final functional role of 
HSPA1 in epileptogenesis remains unclear, with studies indicating its 
neuroprotective role as well as detrimental effects following HSPA1 
administration or internal overexpression present. The ambiguous 
findings might also mirror the fact that activation of glia can serve both 
a protective function and, on the other hand, if the activation becomes 
excessive and persistent, it can also contribute to the pathophysiology 
and disease progression (RAVIZZA et al., 2011; PITKANEN et al., 
2015). The pronounced upregulation of HSPA1 expression in 
epileptogenesis described in this study reflects an endogenous 
mechanism modulating the induction of inflammatory signalling and 
the onset of molecular, cellular, and network reorganisation resulting 
in the generation of a hyperexcitable epileptic network. Nevertheless, 
further research is indispensable to decisively determine the role of 
HSPA1 in the epileptogenic process and develop treatment 
approaches, based either on inhibition or on enhancement of HSPA1 
function. 
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2. HSPA5 and HSPH4 
The present study focused also on the analysis of the expression 
patterns of two endoplasmic chaperones, HSPA5 and HSPH4, in the 
course of epileptogenesis modelled in the adult rat brain. 
Comprehensive information related to epileptogenesis-associated 
alterations in the levels of the abovementioned proteins is necessary 
to better understand the role of ER-stress and the related processes 
in the development of temporal lobe epilepsy. It might be also of use 
while assessing putative therapeutic approaches targeting the 
unfolded protein response. Additionally, information about time-
windows when the alterations are the most pronounced is of high 
relevance to the temporal placement of eventual anti-epileptogenic 
intervention. Quantitative analysis of immunohistochemical stainings 
in rats confirmed the findings from a previous proteomics study in the 
electrical post-SE model, where an early induction of HSPA5 and late 
upregulation of HSPH4 was indicated (WALKER et al., 2016). In 
addition, analogically to the HSPA1 examination, it provided a detailed 
information about the expression patterns in different subregions of 
the hippocampus and the parahippocampal cortex. 
Both proteins of interest underwent changes in expression patterns 
during the latency phase following SE, showing a significant 
upregulation in subregions of the temporal lobe crucial for the 
development of TLE. By definition, the latent period is described as 
the timespan following the brain insult when molecular and cellular 
mechanisms leading to the onset of clinical seizures are progressing. 
Analysis of immunohistochemically stained brain rat tissue revealed 
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the most pronounced alterations of HSPA5 and HSPH4 during this 
phase. This suggests that pathophysiological events linked to the 
commencing epileptogenic process modify the expression of the two 
ER chaperones, and that status epilepticus, as well as following early 
post-insult recovery phase, influence their levels to a lesser extent, 
having an impact only on HSPA5. Epileptogenesis has already been 
demonstrated to trigger upregulation of various markers of ER stress, 
including HSPA5, in the kindling models in rats (CHIHARA et al., 2011) 
and mice (ZHU et al., 2017).  It is therefore plausible that 
cytomolecular changes in the neuronal circuitry in the course of 
epileptogenesis lead to increased endoplasmic reticulum stress with 
following upregulated expression of HSPA5 and HSPH4. 
The expression pattern of both proteins varied in response to the 
epileptogenic insult, but this variation was restricted regionally. The 
piriform, the perirhinal and the entorhinal cortex as well as CA1 region 
of the hippocampus were the areas affected the most. The piriform 
cortex demonstrated changes in expression levels of both proteins of 
interest. However, HSPA5 showed alterations as the consequence of 
status epilepticus restricted only to layer 1, the most superficial part of 
the region consisting mostly of axons and glial cells, while HSPH4 
exhibited changes in the layer 2, the portion of the piriform cortex 
containing the most of the neuronal cell bodies. The piriform cortex, 
due to its interconnectivity to other hyperexcitability-prone areas as 
well as to its low inhibitory GABAergic connectivity, especially in area 
tempestas, is a region particularly susceptible to pro-convulsive 
stimulation and capable of generating seizures (PIREDDA & GALE, 
1985). It is plausible that strong hyperexcitatory activity of neurons of 
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the piriform cortex causes the most pronounced effect on HSPA5 and 
HSPH4 expression among all the investigated regions. 
HSPH4 levels were found to be upregulated in SE animals also in the 
perirhinal and the entorhinal cortices. These two temporal lobe 
subregions play an important role in the brain connectivity serving as 
an interface of sensory inputs between the hippocampal formation and 
other limbic as well as cortical areas, relaying the signal in both 
directions (WITTER & GROENEWEGEN, 1986). As a result of their 
strategic location and high interconnectivity, the abovementioned 
regions serve as crucial elements for the progression of epileptogenic 
alterations (VISMER et al., 2015). In the hippocampus, HSPH4 was 
upregulated in CA1 region in SE rats and in dogs with structural 
epilepsy. This Cornu Ammonis subregion is involved in a complex 
circuitry, particularly vulnerable to abnormal neuronal activity and 
susceptible to long-term potentiation of their principal neurons, leading 
in the end to construction of a primary focus able to exhibit 
spontaneous epileptiform discharges (DESHMUKH & KNIERIM, 
2012). The upregulation of HSPH4 on the spot of development of a 
putative epileptic focus as well as in the regions highly connected to it 
further supports a conclusion that ER stress might be related to the 
process of epileptogenesis. 
Qualitative analysis of HSPA5 and HSPH4 expression in different 
brain cell populations revealed a predominant colocalisation of both 
proteins with a neuronal marker (NeuN) and no colocalisation with a 
microglial marker (Iba1). Restricted colocalisation has been observed 
between an astrocytic marker (GFAP) and HSPA5, but not HSPH4. 
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These findings suggest that high ER stress is exerted on neurons, 
which are the main cells involved in the development of dysfunctional 
circuitry in the course of epileptogenesis. The glial response to the 
conditions following status epilepticus was in this case either too weak, 
or the selected time points of two days, ten days and eight weeks after 
the initial insult did not allow us to grasp any relevant changes in these 
cell populations. For instance, in case of rapid glial response it might 
have been too late to notice HSPH4 alterations in glia, due to the short 
half-life of the protein, estimated for around 10.77 hours (XIAO & WU, 
2017). Admittedly, the half-life of HSPA5 is relatively long, it is 
however present in high basal concentrations in the cells 
(PREISSLER & RON, 2019), therefore its alterations could have been 
imperceptible. Additionally, high variance of these basal values in the 
control groups can further clarify relatively low and limited HSPA5 
upregulation in the investigated areas. 
Neuronal HSPA5 and HSPH4 proved to exert protective effects as a 
response to stress factors. HSPA5 acted neuroprotectively in a stroke 
mouse model by binding to and decreasing an overactivation of the 
protein kinase RNA-like endoplasmic reticulum kinase (PERK) arm of 
the UPR, which leads to deleterious consequences for cellular 
homeostasis (LOUESSARD et al., 2017). The protein plays also a 
relevant role in neuroprotection in many common neurodegenerative 
diseases, like Alzheimer’s disease, Parkinson’s disease and 
amyotrophic lateral sclerosis (CASAS, 2017), promoting cell survival 
and decreasing degeneration. HSPH4 has been demonstrated to be 
expressed by neurons in response to glutamate. The cells showed 
higher viability following kainate administration in transgenic mice 
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overexpressing the protein (KITAO et al., 2001). HSPH4 
overexpression was also confirmed following hypoxic stress in 
neuronal culture (TAMATANI et al., 2001). A crucial role in cell survival 
is also displayed in physiological conditions such as brain 
development. HSPH4 is induced in cerebellar Purkinje cells in mice 
during a period of their highest vulnerability to cell death and targeted 
neuronal HSPH4 overexpression improved neuronal viability in 
Purkinje cell layer over the critical period (KITAO et al., 2004). Since 
HSPA5 and HSPH4 seem to be of high importance for promotion of 
neuronal survival and decrease of neurodegeneration, both in 
physiological and pathological conditions, it is plausible that similar 
neuroprotective mechanisms might apply in case of status epilepticus 
and its early results as well as subsequent epileptogenic processes. 
Since the rat model of electrical SE takes into consideration highly 
standardized, laboratory conditions, a glimpse into more unpredictable 
clinical environment can add more relevant information to the picture 
of HSPA5 and HSPH4 expression in epileptic brain. For that purpose, 
analysis on the canine brain tissue was performed. Data from patients 
handled in the clinics can be directly compared to the results obtained 
from the chronic phase with spontaneous recurrent seizures in the rat 
model, since this phase mirrors the actual presentation of TLE. Rats 
used in this study presented no significant differences in levels of 
HSPA5 and HSPH4 between experimental and control group during 
this phase. On the other hand, analysis performed in the 
immunohistochemically stained brain samples collected from dogs, 
indicated an increase of area of the HSPH4 staining in patients with 
structural type of epilepsy. No differences were however observed in 
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case of HSPA5. 
There is discrepancy in the data between the rat and the dog models 
and its nature is not completely clear. It might be related to differences 
between the two species and could be influenced by drug treatment, 
duration of the disease, age, breed, co-morbidities etc. However, this 
finding might to some extent suggest that ER stress-related response 
might be involved also when symptoms are fully developed, so 
therapeutic targeting of the respective heat shock protein could be 
advantageous also in the chronic phase of the disease. Additional 
research involving more clinical cases is nevertheless necessary to 
elucidate the relevance of HSPA5 and HSPH4 to TLE manifestation. 
In addition to regulation of protein expression itself, one has to address 
posttranslational regulation of function as well. In the ER, HSPA5 is 
present in two distinct states, active or inactive, which depends on 
AMPylation, locking the protein in low-affinity state for its substrates 
(PREISSLER & RON, 2019). HSPA5 may also be deposited into a 
pool of temporarily inactive proteins in a process of oligomerisation 
(PREISSLER & RON, 2019). Therefore, in an environment where 
substrates of the chaperone are lacking, HSPA5 can still be abundant 
in cells, but either in its inactive AMP-bound form, or accumulated in 
form of oligomers. All of these posttranslational alterations of HSPA5 
were not in the scope of this study, therefore it might be of future 
interest to investigate a presumptive impact of epileptogenic insult on 
HSPA5 cellular fractions. 
The unfolded protein response has been already proposed as a 
possible target of novel therapeutic strategies. The process has been 
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discussed in terms of anti-cancer therapy (WANG et al., 2018b), in 
cardiovascular disease (ZHANG et al., 2019) as well as in 
neurodegenerative diseases (HUGHES & MALLUCCI, 2019; 
MARTINEZ et al., 2019). Modulation of HSPA5 levels has been 
suggested in oncology. Cleavage of HSPA5 polypeptides was 
demonstrated to result in lower cancer cell survival (BACKER et al., 
2011). Several therapeutic agents regulating HSPA5 expression have 
been described in models of Parkinson’s disease, where they exerted 
a neuroprotective effects (ENOGIERU et al., 2019). 
Possible therapy strategies could be also developed, considering the 
physical and functional link between endoplasmic reticulum and 
mitochondria. Both organelles are in close contact by their 
membranes, where 20% of the mitochondrial surface is linked directly 
to the ER (KORNMANN et al., 2009). These linking sites through 
which ER communicates with mitochondria are referred to as 
mitochondrial-associated membranes (MAMs) and their interaction is 
critical for calcium signaling flowing from the ER into the mitochondria 
(MALHOTRA & KAUFMAN, 2011). The machinery of the MAMs 
involved in calcium efflux consists of inositol triphosphate receptor 
(IP3R), an important Ca2+ channel, as well as sigma-1R receptor, 
which along with HSPA5 forms a complex bound to IP3R 
(MALHOTRA & KAUFMAN, 2011). Under conditions of ER stress, 
sigma-1 receptors have been demonstrated to dissociate from HSPA5 
and interact directly with IP3R, subsequently prolonging calcium 
signaling from the ER to mitochondria and ultimately promoting cell 
survival (NGUYEN et al., 2015). Targeting sigma-1R is a concept 
already being discussed in epileptology, since allosteric modulations 
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of the receptor provided anti-seizure effects in pentylenetetrazole and 
kainic acid-induced status epilepticus rat models (GUO et al., 2015; 
VAVERS et al., 2017). Additional modulation of HSPA5, which plays 
a key role in sigma-1R functionality, might be of further advantage in 
developing therapy approaches targeted towards this complex. 
Interestingly, the unfolded protein response seems to be connected to 
inflammation and subsequent production of cytokines (SMITH, 2018). 
In a study performed on cultured macrophages, production of anti-
inflammatory interleukin 10 was greatly reduced by ER stress, while 
the levels of pro-inflammatory interleukin 12 messenger RNA were 
elevated (ZHANG et al., 2019). In the course of the UPR, a chaperone 
protein known as heat shock protein C4 (HSPC4, also known as 94 
kDa glucose-regulated protein, GRP94, and HSP90B1) is upregulated 
in response to misfolded proteins. HSPC4 is recognised to regulate 
levels of TLRs by folding TLR1, 2, 4, 7 and 9 specifically 
(TIMBERLAKE et al., 2018), influencing directly their expression in cell 
membranes and, subsequently, the intensity of the inflammatory 
response in the cell. It is therefore plausible that cellular stress 
associated with excessive excitatory signaling during status 
epilepticus triggers upregulation of HSPC4 throughout the unfolded 
protein response. Consequently, TLRs expression gets upregulated, 
facilitating initiation of production of pro-inflammatory cytokines in the 
cell as well as their release into the extracellular matrix, which 
establishes an environment promoting seizure generation, but also 
further exacerbating the UPR, creating a positive feedback loop 
(SMITH, 2018). 
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This further connects heat shock proteins and processes involving 
HSPs to epileptogenesis, which makes them promising candidates for 
future therapeutic targets. In the case of HSPA5 and HSPH4 however, 
additional studies with genetic and pharmacological modulation of 
both proteins with subsequent analysis of the consequences in animal 
models of temporal lobe epilepsy are necessary to elucidate their 
impact on the process of the development of the disease. 
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VII. CONCLUSIONS 
 
All heat shock proteins of interest analysed in this study exhibited 
altered expression patterns in the course of epileptogenesis. 
Moreover, HSPH4 underwent changes also in case of canine patients 
diagnosed with structural epilepsy. Those findings prove that epileptic 
events influence the expression rates of proteins involved in response 
to stress  and are involved in inflammatory reactions (HSPA1) and in 
unfolded protein response (HSPA5, HSPH4). 
HSPA1 was intensely upregulated in the early phase following status 
epilepticus, therefore it is plausible that the protein might contribute to 
excessive inflammation which later on contributes to cellular and 
molecular changes leading to formation of hyperexcitable networks 
and generation of epileptic focus. Therefore, targeting HSPA1 in the 
early post-insult phase could be worth of consideration in development 
of novel therapeutic approaches. 
HSPA5 and HSPH4 exhibited the most pronounced upregulation 
mainly in the latency phase of the epileptogenesis. This finding 
suggests that endoplasmic stress is exerted on cells when the 
cytomolecular epileptogenic changes progress in the brain tissue. 
Furthermore, this result indicates that therapy strategies targeting 
these proteins should be aimed on this time point of the process. 
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VIII. SUMMARY  
Epilepsies are common chronic diseases with high burden both in 
veterinary practice and in human medicine. Due to many obstacles in 
standard therapeutic procedures leading to ineffective treatment, 
development of new targeting strategies is necessary. A good starting 
point is preventing or hindering the process of epileptogenesis, when 
all the mechanisms driving the pathologic alterations in the brain 
commence and proceed. 
The link between epileptogenesis and inflammation has been already 
established. It is known that epileptogenic insults can start 
inflammatory processes as well as that inflammation can sustain and 
progress epileptogenesis. Therefore, modification of pro-inflammatory 
signalling within a cell would make a possibly efficient therapy 
strategy. Among cascades leading to inflammation, the one of Toll-like 
receptor 4 (TLR4) is of particular interest, due to its known contribution 
to generation of seizures. Ligands of TLR4 include pathogen-derived 
as well as endogenous molecules, among them heat shock protein A1 
(HSPA1). 
The unfolded protein response is a set of processes started by stress 
exerted on endoplasmic reticulum. Gathering of misfolded peptides is 
a factor precipitating the response, which in the end leads to 
upregulation of chaperones. Among them, heat shock protein A5 
(HSPA5) and heat shock protein H4 (HSPH4) play important roles in 
bringing back the homeostasis inside the organelle. The unfolded 
protein response is known to contribute to many neurological 
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disorders. 
To investigate alterations that the three heat shock proteins undergo 
following an epileptogenic insult, single and multiple 
immunohistochemistry was performed in brains collected from rats of 
temporal epilepsy model as well as in canine tissue from clinical 
cases. In the rat temporal lobe epilepsy model, stereological cell 
counting revealed a clear upregulation of HSPA1 expression in all 
investigated regions of the hippocampus and the parahippocampal 
cortex in the early post-insult phase. Upregulation of HSPA5 and 
HSPH4 expression was spatially restricted, present predominantly in 
the parahippocampal cortex, mostly in the latency phase. All of the 
heat shock proteins were expressed by neurons, and restricted 
expression was observed in microglia (HSPA1) and in astroglia 
(HSPA5). In canine tissue, quantitative analysis revealed an increase 
of HSPH4 expression in brains collected from patients diagnosed with 
structural epilepsy in Cornu Ammonis 3 region of the hippocampus. 
These findings advocate an influence of status epilepticus and of the 
subsequent epileptogenic process on regulation of heat shock 
proteins expression. Considering involvement of HSPA1 in 
inflammatory cascade, possible modifications of expression of this 
protein could be a suitable therapeutic strategy. However, it has to be 
firstly elucidated, whether HSPA1 acts protectively or deleteriously as 
an element of the Toll-like receptor 4 inflammatory cascade. 
At the same time, hampering the progression of the process may be 
achieved by modifications of endoplasmic heat shock proteins, 
HSPA5 and HSPH4, involved in local stress response and expressed 
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predominantly during the latency phase. More research however is 
necessary, involving genetic and pharmacological modulation of both 
proteins in vivo. 
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IX. ZUSAMMENFASSUNG 
Epilepsien sind chronische, höchstbelastende Erkrankungen, die 
sowohl in der Veterinär- als auch in der Humanmedizin weit verbreitet 
sind. Viele Patienten sprechen nicht auf eine pharmakologische 
Therapie an und können daher nicht effektiv behandelt werden. Aus 
diesem Grund ist die Entwicklung neuer therapeutischer Strategien 
und das Finden neuer therapeutisch nutzbarer Zielstrukturen 
notwendig. Dabei ist es ein Hauptziel der epileptologischen Forschung 
Strategien zu entwickeln, die den Prozess der Epilepsieentstehung 
unterbrechen. Aus der Literatur ist bekannt, dass epileptische Anfälle 
inflammatorische Prozesse induzieren und dass inflammatorische 
Prozesse die Epileptogenese induzieren und forcieren können. 
Deswegen könnte eine Modifizierung von pro-inflammatorischen 
Signalkaskaden möglicherweise eine effiziente Präventionsstrategie 
darstellen. In diesem Zusammenhang ist die Toll-like-Rezeptor-
4(TLR4)-Signalkaskade von besonderem Interesse. Die Liganden des 
TLR4 umfassen verschiedene endogene Moleküle, unter anderem 
auch das Hitze-Schock-Protein A1 (HSPA1). 
Die zelluläre Antwort auf ungefaltete Proteine umfasst komplexe 
Reaktionen, die durch zelluläre Stressfaktoren ausgelöst werden, 
welche das endoplasmatische Retikulum beeinflussen. Die 
Kumulation von fehlerhaft gefalteten Peptiden ist ein Faktor, der die 
Antwort beschleunigt, was im Endeffekt zur Hochregulierung von 
Chaperon-Proteinen führt. Unter den Chaperon-Proteinen spielen 
Hitze-Schock-Protein A5 (HSPA5) und Hitze-Schock-Protein H4 
(HSPH4) eine wichtige Rolle für die Wiederherstellung der 
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Homöostase. Die zelluläre Antwort auf ungefaltete Proteine scheint 
zur Pathophysiologie verschiedener neurologischer Erkrankungen 
beizutragen. 
Um die Veränderungen der Expressionsraten der drei Hitze-Schock-
Proteine in Folge von epileptischen Anfällen zu untersuchen, wurden 
qualitative und quantitative immunhistochemische Untersuchungen 
an Gehirnschnitten von Ratten während der Epileptogenese sowie an 
Gehirnen von Hundepatienten durchgeführt. In der frühen Post-Insult-
Phase des Rattenmodells der Temporallappenepilepsie konnte durch 
stereologische Zellzählung eine erhöhte Zahl HSPA1-exprimierender 
Zellen in allen untersuchten Regionen des Hippocampus und des 
parahippocampalen Cortex in der frühen Post-Insult-Phase 
nachgewiesen werden. Eine Überexpression von HSPA5 und HSPH4 
zeigte sich hingegen nur in einzelnen Hirnregionen, wie dem 
parahippocampalen Cortex. Alle im Rahmen dieses 
Forschungsprojektes analysierten Hitze-Schock-Proteine waren in 
Neuronen exprimiert und zusätzlich vereinzelt in Mikrogliazellen 
(HSPA1) und in Astrozyten (HSPA5). Die quantitative Analyse im 
Hundegewebe zeigt eine Erhöhung der HSPH4-Expression in der 
Cornu-Ammonis-3-Region des Hippocampus in Gehirnen von 
Patienten mit struktureller Epilepsie. 
Die Ergebnisse zeigen, dass ein Status Epilepticus als epileptogener 
Insult und der Prozess der Epileptogenese einen Einfluss auf die 
Expression von Hitze-Schock-Proteinen ausübt. Angesichts der 
Beteiligung von HSPA1 in der Inflammationskaskade könnte 
möglicherweise eine gezielte Modulation der Expression dieses 
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Proteins eine geeignete neue Therapiestrategie darstellen. Allerdings 
muss zuerst abgeklärt werden, ob HSPA1 als ein Element der TLR4-
Entzündungskaskade nach epileptogenen Insulten protektive oder 
schädliche Eigenschaften besitzt. 
Möglicherweise könnte der Prozess der Epileptogenese außerdem 
durch eine Modulation der endoplasmatischen Hitze-Schock-
Proteine, HSPA5 und HSPH4, beeinflusst werden. Diese beiden 
Proteine sind an der lokalen Stressantwort beteiligt und werden 
vorüberwiegend in der Latenzphase der Epileptogenese exprimiert. 
Weiterführende funktionelle Studien, insbesondere die genetische 
und pharmakologische Modulation dieser Proteine in vivo, sind jedoch 
eine Voraussetzung, um eine abschließende und umfassende 
Aussage treffen zu können. 
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1. Software and devices 
Instrument Producent 
Affinity Photo Serif (Europe) Ltd, United 
Kingdom 
Axiocam Carl Zeiss Microscopy GmbH, 
Germany 
Axiovision AxioVision, 
RRID:SCR_002677, Carl 
Zeiss Microscopy GmbH, 
Germany 
BH2 bright field 
microscope 
Olympus, Japan 
Centrifuge 5418 Eppendorf, Wesseling-
Berzdorf, Germany 
Confocal laser 
scanning microscope 
Zeiss LSM880 
Zeiss LSM 880 with Airyscan, 
RRID:SCR_015963, Carl 
Zeiss Microscopy GmbH, 
Germany 
Cover slips H878.2, Carl Roth, Germany 
Cryostat Microm 
HM560 
Thermo Fisher Scientific, USA 
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EndNote X8 EndNote, RRID:SCR_014001, 
Clarivate Analytics, USA 
Fiji Fiji, RRID:SCR_002285, 
National Institutes of health, 
USA 
GraphPad Prism 5 GraphPad Prism, 
RRID:SCR_002798, 
GraphPad Software Inc., USA 
ImageJ ImageJ, RRID:SCR_003070, 
National Institutes of health, 
USA 
Keyence BZ X-710 
fluorescent microscope 
BZ X-710 fluorescent 
microscope, 
RRID:SCR_017202, Keyence, 
Japan 
BZ Analyzer BZ Analyzer software, 
RRID:SCR_017205, Keyence, 
Japan 
Leica DMLB bright field 
microscope 
Leica Microsystems GmbH, 
Germany 
Magnetic stirrer with 
heating plate 
VWR International GmbH, 
Germany 
Magnetic stirring bars VWR International GmbH, 
Germany 
Microsoft Office Microsoft Corporation, USA 
Motorised stage MBF Bioscience, USA 
OCT Compound Electron Microscopy Sciences 
– USA 
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Personal computer Diverse 
pH-meter Hanna instruments, Croatia 
Precision cover glasses 
thickness No. 1.5H 
Paul Marienfeld GmbH & Co. 
KG, Germany 
Shaker Unimax 1010 Heidolph Instruments GmbH & 
Co. KG, Germany 
Stereo Investigator 
11.0 
Stereo Investigator, 
RRID:SCR_002526, MBF 
Bioscience, USA 
SuperFrost Plus 
microscope slides  
Thermo Fisher Scientific, USA 
Vortexer LMS® VTX-
300OL Mixer UZUSIO 
Hartenstein, Germany 
Water bath Typ 24900 Medax Nagel GmbH & Co KG, 
Germany 
Zen software: Black 
edition 
ZEN Digital Imaging for Light 
Microscopy, 
RRID:SCR_013672, Carl 
Zeiss Microscopy GmbH, 
Germany 
Zen software: Blue 
edition 
ZEN Digital Imaging for Light 
Microscopy, 
RRID:SCR_013672, Carl 
Zeiss Microscopy GmbH, 
Germany 
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2. Solutions and substances 
Solutions 
3,3’-diaminobenzidine reaction solution 
Antibody carriers (depending on the staining) 
Block (depending on the staining) 
Hoechst 33342 working solution 
Hydrogen peroxide working solution 
PBS 
PBS-T 
Sodium citrate buffer 
TBS 
TBS-T 
Tris-Nickel solution 
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Substances 
Substance Producer 
Primary antibodies: 
Anti-GFAP antibody 
(mouse, monoclonal, clone 
2A5) 
Abcam Cat# ab4648, 
RRID:AB_449329, Lot# 
GR309691-7 
Anti-GFAP antibody (rabbit, 
polyclonal) 
Abcam Cat# ab7260, 
RRID: AB_305808, Lot# 
2549361 
Anti-GRP78 BiP antibody 
(rabbit, polyclonal) 
Abcam Cat# ab21685, 
RRID:AB_2119834, Lot# 
GR3192839-1 
Anti-Hsp70/Hsp72 antibody 
(mouse, monoclonal, clone 
C92F3A-5) 
Enzo Life Sciences Cat# 
ADI-SPA-810, RRID: 
AB_10616513, Lot# 
05011728 
Anti-Iba1 antibody (goat, 
polyclonal) 
Abcam Cat# ab107159, 
RRID:AB_10972670, Lot# 
GR3209953-1 
 
Anti-Iba1 antibody (rabbit, 
polyclonal) 
Wako Cat# 019-19741, 
RRID: AB_839504, Lot# 
WDE1198 
Anti-NeuN antibody 
(mouse, monoclonal, clone 
A60) 
Millipore Cat# MAB377, 
RRID: AB_2298772, Lot# 
3018822 
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Anti-ORP150/HSP12A 
antibody (rabbit, polyclonal) 
Novus Cat# NBP1-32140, 
RRID:AB_2123515, Lot# 
39785 
Anti-TLR4 antibody 
(mouse, monoclonal, clone 
25) 
Santa Cruz Biotechnology 
Cat# sc-293072, RRID: 
AB_10611320, Lot# 
L1117 
Secondary antibodies: 
Alexa Fluor 488 Goat anti-
Mouse 
Thermo Fisher Scientific 
Cat# A-11029, RRID: 
AB_2534088, Lot# 
1911843 
Alexa Fluor 594 Goat anti-
Rabbit 
Thermo Fisher Scientific 
Cat# A-11012, RRID: 
AB_2534079, Lot# 
1892265 
Alexa Fluor 647 Goat anti-
Rabbit 
Thermo Fisher Scientific 
Cat# A-21244, RRID: 
AB_2535812, Lot# 
1910774 
Cy2 Goat anti-Mouse Jackson 
ImmunoResearch Labs 
Cat# 115-225-166, RRID: 
AB_2338746, Lot# 
122679 
Cy2 Donkey anti-Goat Jackson 
ImmunoResearch Labs 
Cat# 705-225-147, 
RRID:AB_2307341, Lot# 
133888 
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Biotinylated goat anti-
mouse 
Dako Cat# E0433, RRID: 
AB_2687905, Lot# 94167 
Biotinylated goat anti-
mouse 
Vector Laboratories Cat# 
BA-9200, RRID: 
AB_2336171, Lot# 
ZB0324 
Biotinylated goat anti-rabbit Vector Laboratories Cat# 
BA-1000, 
RRID:AB_2313606, Lot# 
ZC0908 
Chromogens: 
3,3'-diaminobenzidine 
tetrahydrochloride 
CN75 - Carl Roth, 
Germany 
Ammonium nickel(II) sulfate 
hexahydrate 
A1827, Sigma Aldrich, 
Germany 
ABC-Peroxidase Kit Vector Laboratories Cat# 
PK-4003, 
RRID:AB_2336812 
Cy3-Streptavidin Jackson 
ImmunoResearch Labs 
Cat# 016-160-084, RRID: 
AB_2337244), Lot# 
136321 
Hoechst 33342 H3570, Thermo Fisher 
Scientific, Germany 
Peroxidase-Streptavidin Jackson 
ImmunoResearch Labs 
Cat# 016-030-084, RRID: 
AB_2337238, Lot# 
126142 
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Others: 
2-propanol (for cleaning 
microscope slides) 
9866.2 – Carl Roth, 
Germany 
Bovine serum albumin A9647 - Sigma-Aldrich 
Chemie GmbH, Germany 
Casein from bovine milk C3400 - Sigma-Aldrich 
Chemie GmbH, Germany 
Entellan mounting medium 1 07960 - Merck KGaA, 
Germany 
Ethanol 50%, 70%, 95% 
and 99.9% 
AgrAlko AG, Germany 
Gelatine from cold water 
fish skin 
G7041 - Sigma-Aldrich 
Chemie GmbH, Germany 
Hydrogen peroxide 30% 9681.4- Carl Roth, 
Germany 
Immersol™ 518 F 
immersion medium 
Carl Zeiss Microscopy 
GmbH, Germany 
Immersol™ W 2010 
immersion medium 
Carl Zeiss Microscopy 
GmbH, Germany 
Immunoselect antifading 
mounting medium 
Dianova Cat# SCR-
038447, RRID: 
AB_2661796, Lot# 30518 
Millipore water Merck Millipore, USA 
Normal goat serum VEC-S-1000 – Vector 
Labs, USA 
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Sodium chloride 9265.1 – Carl Roth, 
Germany 
Sodium hydrogen 
phosphate 
T876.3 – Carl Roth, 
Germany 
Potassium chloride P9541 – Sigma Aldrich, 
Germany 
Potassium dihydrogen 
phosphate 
26936.293P – VWR 
International GmbH, 
Germany 
Tris(hydroxymethyl)aminom
ethane 
470302-966 - VWR 
International GmbH, 
Germany 
Trisodium citrate dehydrate 3580.3 – Carl Roth, 
Germany 
Triton X-100 X100 – Sigma Aldrich, 
Germany 
Tween 20 P1379 – Sigma Alrich, 
Germany 
Xylene (isomers) 9713.3 – Carl Roth, 
Germany 
 
  
172 
3. Protocols for immunohistochemistry 
IHC in DAB 
In 12 well plates with NetWells® 
 3 × 5 min wash in TBS 1X 
 1 x 30 min Heat Induced Epitope Retrieval (HIER) with sodium 
citrate (pH 6) in water bath pre-heated at 80 °C 
 1 x 10 min cool down 
 3 × 5 min wash in TBS 1X 
 30 min 3% H2O2 – TBS 1X 
 3 × 5 min wash in TBS 1X 
In 24 well plates 
 1 x 60 min in blocking buffer 
 Primary antibody incubation overnight in carrier at 4 °C (cold 
room) 
In 12 well plates with NetWells® 
 3 × 5 min wash in TBST 1X 
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In 24 well plates 
 Secondary antibody incubation 60 min 1:1000 in carrier at 
room temperature 
In 12 well plates with NetWells® 
 3 × 5 min wash in TBST 1X 
In 24 well plates 
 ABC kit incubation 60 min in PBST at room temperature. 
In 12 well plates with NetWells® 
 3 × 5 min wash in TBS 1X 
 5 min DAB solution 
 2 × 5 min wash in TBS 1X 
 Quickly rinse with bidistilled H2O 
 Use TBST to mount brain slices on microscope slides 
 Dry microscope glass overnight at room temperature 
 Quickly rinse with xylene 
 Coverslip with Entellan 
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Double immunofluorescence – parallel incubation of 
primary antibodies 
In 12 well plates with NetWells® 
 3 × 5 min wash in PBST 1X 
 1 x 30 min Heat Induced Epitope Retrieval (HIER) with sodium 
citrate (pH 6) in water bath pre-heated at 80 °C 
 1 x 10 min cool down 
 3 × 5 min wash in PBST 1X 
In 24 well plates 
 1 x 60 min in blocking buffer 
 First primary antibody incubation overnight in carrier at 4 °C 
(cold room) 
 Second primary antibody incubation overnight in carrier at 4 
°C (cold room) 
In 12 well plates with NetWells® 
 3 × 5 min wash in PBST 1X 
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In 24 well plates – from now on work in darkened room to preserve 
fluorophore 
 First secondary antibody incubation 60 min (for Cy2-donkey 
anti-goat: 90 min) in carrier at room temperature 
 Second secondary antibody incubation 60 min incubation 60 
min in carrier at room temperature 
Additional step for staining requiring streptavidin: 
In 12 well plates with NetWells® 
 3 × 5 min wash in PBST 1X 
In 24 well plates 
 Streptavidin-fluorophore incubation 60 min at room 
temperature 
In 12 well plates with NetWells® 
 3 × 5 min wash in PBS 1X 
 1 × 30 s incubation in Hoechst 33342 work solution 
 3 × 5 min wash in PBS 1X 
 Use 0,1x PBST to mount brain slices on microscope slides 
 1 x 15 min dry microscope glass on heated plate at 45 °C 
 Coverslip with Dianova IS Mounting Medium 
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Double immunofluorescence – sequential incubation of 
primary antibodies 
In 12 well plates with NetWells® 
 3 × 5 min wash in PBST 1X 
 1 x 30 min Heat Induced Epitope Retrieval (HIER) with sodium 
citrate (pH 6) in water bath pre-heated at 80 °C 
 1 x 10 min cool down 
 3 × 5 min wash in PBST 1X 
In 24 well plates 
 1 x 60 min in blocking buffer 
 First primary antibody incubation overnight in carrier at 4 °C 
(cold room) 
In 12 well plates with NetWells® 
 3 × 5 min wash in PBST 1X 
In 24 well plates - from now on work in darkened room to preserve 
fluorophore 
 First secondary antibody incubation 60 min in carrier at room 
temperature 
In 12 well plates with NetWells® 
 3 × 5 min wash in PBST 1X 
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In 24 well plates 
 Second primary antibody incubation overnight in carrier at 4 
°C (cold room) 
In 12 well plates with NetWells® 
 3 × 5 min wash in PBST 1X 
In 24 well plates 
 Second secondary antibody incubation 60 min in carrier at 
room temperature 
Additional step for staining requiring streptavidin: 
In 12 well plates with NetWells® 
 3 × 5 min wash in PBST 1X 
In 24 well plates 
 Streptavidin-fluorophore incubation 60 min at room 
temperature 
In 12 well plates with NetWells® 
 3 × 5 min wash in PBS 1X 
 1 × 30 s incubation in Hoechst 33342 work solution 
 3 × 5 min wash in PBS 1X 
 Use PBST 1X to mount brain slices on microscope slides 
 1 x 15 min dry microscope glass on heated plate at 45 °C 
 Coverslip with Dianova IF-mounting medium 
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Triple immunofluorescence 
The first and the second antibody come from the same host species 
In 12 well plates with NetWells® 
 3 × 5 min wash in PBST 1X 
 1 x 30 min Heat Induced Epitope Retrieval (HIER) with sodium 
citrate (pH 6) in water bath pre-heated at 80 °C 
 1 x 10 min cool down 
 3 × 5 min wash in PBST 1XIn 24 well plates 
 1 x 60 min in blocking buffer 
 First primary antibody incubation overnight in carrier at 4 °C 
(cold room) 
In 12 well plates with NetWells® 
 3 × 5 min wash in PBST 1X 
In 24 well plates - from now on work in darkened room to preserve 
fluorophore 
 First secondary antibody incubation in carrier 60 min at room 
temperature 
In 12 well plates with NetWells® 
 3 × 5 min wash in PBST 1X 
In 24 well plates 
 Second primary antibody incubation overnight in carrier at 4 
°C (cold room) 
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 Third primary antibody incubation overnight in carrier at 4 °C 
(cold room) 
In 12 well plates with NetWells® 
 3 × 5 min wash in PBST 1X 
In 24 well plates 
 Second secondary antibody incubation in carrier 60 min at 
room temperature  
 Third secondary antibody incubation in carrier 60 min at room 
temperature 
Additional step for staining requiring streptavidin: 
In 12 well plates with NetWells® 
 3 × 5 min wash in PBST 1X 
In 24 well plates 
 Streptavidin-fluorophore incubation 60 min at room 
temperature 
In 12 well plates with NetWells® 
 3 × 5 min wash in PBS 1X 
 30 s incubation in Hoechst 33342 work solution 
 3 × 5 min wash in PBS 1X 
 Use PBST 1X to mount brain slices on microscope slides 
 1 x 15 min dry microscope glass on heated plate at 45 °C 
 Coverslip with Dianova IF-mounting medium 
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